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ABSTRACT 
Asymmetric Cell Division in the Generation of Immunity and Tolerance 
Bonnie Yen The	immune	system	relies	on	the	collaboration	of	heterogeneous	cell	types	to	respond	to	infection,	develop	immunological	memory,	and	to	maintain	immunological	tolerance.		In	response	to	infection,	naïve	lymphocytes	must	divide	and	give	rise	to	differentiated	effector	cells	while	also	regenerating	a	population	of	memory	cells	that	may	respond	more	efficiently	to	future	infection.		It	has	been	demonstrated	in	B	cells	and	T	cells	that	the	generation	of	these	cell	types	may	be	accomplished	simultaneously	through	asymmetric	cell	division.		The	second	chapter	of	this	thesis	focuses	on	what	factors	may	drive	the	divergence	of	cell	fates	in	asymmetric	cell	division	of	CD8+	T	cells.		We	demonstrate	unequal	expression	of	transcription	factor	TCF1	between	cytokinetic	sibling	cells,	which	may	be	driven	by	unequal	transduction	of	nutrient-sensitive	PI3K/AKT/mTOR	signaling.		In	chapter	three,	we	extend	our	interrogation	of	asymmetric	cell	division	in	lymphocytes	to	the	development	of	regulatory	T	cells,	which	are	important	for	the	maintenance	of	immunological	self-tolerance.		It	has	been	shown	that	there	is	some	overlap	in	the	T	cell	receptor	repertoires	of	Tregs	and	conventional	CD4+	T	cells.		We	propose	that	this	overlap	may	be	a	result	of	an	asymmetric	cell	division,	giving	rise	to	one	Treg	and	one	conventional	CD4+	T	cell.		We	demonstrate	asymmetric	Foxp3	expression	between	cytokinetic	sibling	cells	found	in	the	thymus	as	well	as	from	an	in	vitro	Treg	induction	model.		We	also	show	that	in	vitro	upregulation	of	Foxp3,	the	major	Treg-associated	transcription	factor,	is	inhibited	by	cell	cycle	inhibitors,	further	linking	the	act	of	cell	fate	divergence	to	a	divisional	event.		
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The immune system is a complex and invaluable defense mechanism that protects our 
bodies against foreign pathogens such as bacteria, viruses, and parasites.  It is composed of a 
diverse collection of cells, most of which originate from hematopoietic stem cells, and can be 
divided into two branches: the innate immune system and the adaptive immune system.   
 
Innate immune system 
The innate immune system can be thought of as the front-line of defense against infection.  
It is composed of several layers of general defense mechanisms, which are conserved across 
many organisms including invertebrates and plants.  The most external components are the 
epithelial barriers of skin and mucosa, which produce protective secretions and have specialized 
structural components such as beating cilia.  If a pathogen is able to breach the epithelial layer, 
they may encounter hematopoietic-derived cells, which have varied functions that may address 
the pathogen directly such as phagocytosis or degranulation of cytotoxic proteins (Table 1.1).  
Innate immune cells may use germline-encoded surface and internal receptors referred to 
as pattern recognition receptors (PRRs) to bind pathogen-associated molecular patterns (PAMPs).  
PAMPs are molecules that are nonspecifically associated with groups of pathogens such as 
lipopolysaccharide (LPS) found in the outer membrane of Gram-negative bacteria (Brubaker et 
al., 2015).  There are several types of PRRs: Toll-like receptors (TLRs), C-type lectin receptors 
(CLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), and AIM2-like receptors 
(ALRs).  TLRs and CLRs are membrane-bound, found either on the cell surface or within 




Hematopoietic cells of the 
innate immune system Function 
Neutrophils Phagocytosis, activation of adaptive immune system 
Macrophages 
Phagocytosis, antigen presentation, adaptive immune system 
activation 
Dendritic Cells Phagocytosis, antigen presentation 
Eosinophils 
Killing antibody-coated parasites, especially those too large 
to be phagocytosed  
Basophils Killing IgE antibody-coated parasites, allergic reaction 
Natural Killer Cells Killing virus-infected cells 
Mast Cells Killing IgE antibody-coated parasites, allergic reaction 
Innate Lymphoid Cells 
Macrophage activation, phagocytosis, antigen presentation, 
allergic reaction, regulation of dendritic cells 
 
 
Table 1.1  Hematopoietic cells of the innate immune system 
Innate immunity is facilitated by several cells of the hematopoietic lineage, whose functions vary 
from direct interventions with pathogens to activation of the adaptive immune system.   
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(Brubaker et al., 2015).  The varied localizations of PRRs affect the types of PAMPs they 
encounter and therefore also coordinate their appropriate responses, such as cytokine and 
interferon production, apoptosis, and phagocytosis (Brubaker et al., 2015). 
Innate immunity also includes a humoral element of defense known as complement.  The 
complement system is composed of many different proteins found in plasma, which may interact 
with each other on the surface of pathogens to initiate a cascade of events, leading to 
phagocytosis or formation of a membrane-attack complex (MAC), which forms breaks in the 
membrane to cause cell lysis (Janeway et al., 2001).  
Innate immune cells also function to help activate the adaptive immune system.  Cells 
such as macrophages and dendritic cells are antigen-presenting cells (APCs), which may process 
the phagocytosed pathogen and present antigen on major histocompatibility complexes (MHCs) 
to activate the adaptive immune system. 
 
Adaptive immunity 
Although the innate immune system has rapid responses to invasion and infection, it 
relies on a general mechanism of pathogen recognition.  Unlike the innate immune system, the 
adaptive immune system is highly antigen-specific.  Furthermore, this system is capable of 
establishing long-term mechanisms for recognition of previously experienced pathogens, referred 
to as memory.  Adaptive immunity is carried out by a subset of leukocytes called lymphocytes.  
Lymphocytes consist of T cells and B cells, which have surface receptors that specifically 
recognize and bind antigens, usually proteins.  The adaptive immune response can be broadly 




B cells are responsible for humoral adaptive immunity, whereby secreted proteins 
mediate the immune response to pathogen.  B cells are derived from hematopoietic stem cells 
and develop largely in the bone marrow, but continue maturation in the spleen.  A major 
component of B cell development is the generation of its surface B cell receptors (BCRs).  B 
cells may become activated upon BCR binding, giving rise to plasma cells, which release the 
secreted form of the BCR referred to as antibodies.  These antibodies are responsible for binding 
to and neutralizing the pathogen, inducing complement, promoting degranulation of granulocytes, 
and activating NK cell cytotoxicity (Forthal, 2014). 
In order to explain how B cells produce antibodies, Breinl and Haurowitz first proposed 
the template instructionist theory (Breinl and Haurowitz, 1930), which was further supported by 
Pauling (Pauling, 1940).  This theory suggested that B cells had the potential to produce 
antibodies to any antigen because the antigen with which a B cell interacts may act as a 
patterning template, manipulating the process of antibody folding such that the antibodies 
produced become specific to the template antigen.   
However, it was the clonal selection theory proposed by Burnet (Burnet, 1957) and 
developed from the ideas of Jerne (Jerne, 1955), which revolutionized our understanding of 
antibody production.  Burnet rejected the idea of infinite potential in antibody specificity, and 
proposed that the range of the BCR repertoire was large but limited.  Within this vastly varied 
“sea” of B cells, binding of cognate antigen to the small number of antigen-specific B cells leads 
to proliferation of the clone and an increase in excreted antigen-specific antibody.  His theory 
implied that there was some cell-intrinsic mechanism for producing a highly varied BCR 
repertoire and also introduced a possible mechanism for establishing tolerance through selection.  
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These ideas have since extended to T lymphocytes and have become fundamental to our 
understanding of modern immunology.   
 
T Cells  
Like B cells, T cells also possess highly specific surface receptors, T cell receptors 
(TCRs).  Upon TCR activation, these cells may enact many different functions, including 
inducing cytotoxicity, supporting differentiation and function of other immune cell types, and 
even suppressing immune activity.  
Among “conventional” T cells, there are CD8+ and CD4+ T cells.  CD8+ T cells are also 
referred to as cytotoxic T cells, as they are able to secrete cytotoxic peptides such as granzyme 
and perforin to kill intracellularly-infected cells.  Their activation depends on TCR binding to 
antigen presented on MHC class I.  CD4+ T cells, or helper T cells, are known for their ability to 
support the function of other immune cells by secreting appropriate cytokines.  Activation of 
CD4+ T cells occurs through TCR binding to antigen presented by MHC class II, which is 
expressed on APCs.   
Besides these conventional T cells, there are others such as regulatory T cells (Tregs), 
which support immune tolerance rather than immunity.  Regulatory T cells were first identified 
as a population of CD4+ CD25+ T cells which could suppress the immune response and prevent 
autoimmunity (Sakaguchi et al., 1995).  Tregs suppress immune responses by secreting 
inhibitory cytokines such as TGFβ, IL-10, and IL-35, inducing cytolysis of other immune cells 
through granzyme and perforin secretion or IL-2 deprivation, and expressing inhibitory surface 





T cells are so named because bone marrow-derived hematopoietic precursors migrate to 
the thymus, where they undergo maturation into T lymphocytes.  The thymus is a lobular organ 
located just superior to the heart and internal to the sternum.  Human thymus is multi-lobed, 
while murine thymus is bi-lobed.  This organ is largest in childhood and involutes into fatty 
tissue as the organism ages (Palmer, 2013).  In 1961, Jacques Miller demonstrated that thymus 
was important for the development of T cells, when he observed neonatal thymectomy resulted 
in lymphocyte deficiency and impaired immune defense (Miller, 1961).  Miller also astutely 
posited that T cells leaving the thymus were a group of ‘specially selected cells’ (Miller, 1961).  
In following studies demonstrating that thymic transplant could rescue the defects of neonatal 
thymectomy, Miller also showed that mice developed tolerance to graphs from the thymic donor, 
suggesting that the thymus was a site for tolerance establishment (Miller, 1962).  As suggested, 
the process of thymocyte development involves several selective steps, ensuring the production 
of a varied TCR repertoire that will not induce autoimmunity.  
 
Early thymic progenitors and T cell receptor chain rearrangement 
Lymphoid progenitors from the bone marrow enter the thymus as double negative (DN) 
cells, expressing neither co-receptor CD4 or CD8.  In the thymus, Delta-like Notch ligands 
expressed on thymic stroma activate Notch signaling in lymphoid progenitors.  Notch directly 
activates TCF1 expression, which is essential for early thymic progenitor development 
progression (Germar et al., 2011; Weber et al., 2011) and upregulation of T cell associated genes 
such as Gata3, Bcl11b, CD3e, and Il2ra (Weber et al., 2011).  Notch signaling also promotes 
expression of GATA3 (Taghon et al., 2005), which suppresses the potential for B cell and 
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myeloid cell differentiation (Garćia-Ojeda et al., 2013; Scripture-Adams et al., 2014).  TCF1, 
GATA3, and RUNX1, a transcription factor which is already activated at the hematopoietic stem 
cell stage (North, 2004), work in concert to induce transcription factor Bcl11b (Kueh et al., 
2016).  Expression of Bcl11b marks the developmental step where these early thymic progenitor 
cells may no longer differentiate into natural killer (NK) cells or dendritic cells (Yui et al., 2010; 
Naito et al., 2011).  Together, these transcription factors contribute to the commitment of these 
progenitors to the T cell lineage.      
These thymocytes migrate to the thymic cortex, where they begin the process of 
developing their T cell receptors (TCRs).  Each TCR is a heterodimer composed of either a 
combination of α and β chains or γ and δ chains.  Each β and δ chain is composed of variable 
(V), diversity (D), and joining (J) segments, while α and β chains only have V and J segments.  
The genes encoding these chains contain many copies of V, D, and J segments, with different 
sequences.  In order to generate diversity of TCRs, these thymocytes undergo recombination-
activating gene (Rag) recombinase-dependent random recombination of V, D, and J segments in 
β, γ, and δ chains (Schatz et al., 1989; Oettinger et al., 1990).  In addition to the diversity 
generated from different combinations of V, D, and J segments, additional “junctional diversity” 
is achieved by variable joining between recombined segments (Candéias et al., 1996; Feeney, 
1993; Davis and Bjorkman, 1988).  Expression of a functional γ and δ chain combination defines 
a subset of T cells referred to as γδ T cells, a relatively low-frequency subset of lymphocytes 
with both adaptive and innate-like functions (Vantourout and Hayday, 2013).  The process of 
development into the more common αβ T cell involves the successful recombination of a 
functional β chain, which is then paired with invariable chain pre-Tα as well as co-receptor CD3 
to form a pre-TCR complex (Groettrup et al., 1992, 1993; Saint-Ruf et al., 1994).  Signaling by 
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the pre-TCR marks successful passage through a developmental checkpoint referred to as β-
selection, where thymocytes stop further β chain recombination, undergo a proliferative burst, 
and enter the double positive (DP) stage of development, expressing both CD4 and CD8 
(Aifantis et al., 1998; Dudley et al., 1994; Mallick et al., 1993; Hoffman et al., 1996; 
Mingueneau et al., 2013).  The transition to the DP stage is also dependent on signaling through 
Notch (Wolfer et al., 2002; Ciofani et al., 2004; Schmitt et al., 2004; Ciofani and Zúñiga-
Pflücker, 2005; Maillard et al., 2006). After β-selection, DP thymocytes undergo V-J 
recombination of the α chain until it produces a “positively selectable” receptor or dies from 
neglect (Borgulya et al., 1992; Petrie et al., 1993).   
 
Positive selection 
Because T cells interact with antigens which must be presented by MHC, it is important 
that their development involves a process which selects for T cells that can interact with self 
MHC, referred to as positive selection.  Positive selection of αβ thymocytes involves binding of 
sufficient strength between the thymocyte TCR to MHCs on thymic stromal cells (Bevan, 1977; 
Zinkernagel et al., 1978; Hogquist et al., 1994; Sebzda et al., 1994; Ashton-Rickardt et al., 1994).  
This rescues thymocytes from death by neglect via expression of anti-apoptotic proteins Mcl-1 
and Bcl-2 (Dunkle et al., 2010; Dzhagalov et al., 2008; Carpenter and Bosselut, 2010).  
Successful positive selection also depends on the expression of Bcl11b (Albu et al., 2007).  
Rearrangement of the α chain may continue if previous iterations fail to induce positive 
selection.  However, since the DP thymocyte only lives for 3-4 days, most cells fail to be 
positively selected and die from neglect (Starr et al., 2003).  Selection on MHC class I leads to a 
transition to single positive CD8+ CD4- (CD8 SP) phenotype, while selection on MHC class II 
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leads to development of single positive CD4+ CD8- (CD4 SP) phenotype (Kisielow et al., 1988; 
Kaye et al., 1989; Teh et al., 1988).  This process establishes MHC-specificity of CD4 and CD8 
T cells.  Survival through this DP to SP stage has been shown to rely on NFAT proteins, as 
deletion of transcription factor NFAT4 has been reported to reduce the number of SP thymocytes 
and increase apoptosis of DP thymocytes (Oukka et al., 1998). 
 
Negative selection 
While the process of positive selection ensures that T cells are able to interact with self-
MHC, T cells which have high reactivity risk inducing autoimmunity in the organism.  One 
mechanism of central tolerance (developed in the thymus) is the process of negative selection, 
which eradicates developing thymocytes with high reactivity to self-antigen. 
A consequence of positive selection is the upregulation of CCR4, CCR7, and CCR8, 
which facilitates migration of the thymocyte into thymic medulla (Kim et al., 1998; Campbell et 
al., 1999; Bleul and Boehm, 2000; Kwan and Killeen, 2004; Ueno et al., 2004; Hu et al., 2015; 
Ehrlich et al., 2015; Thyagarajan et al., 2016), where negative selection may take place.  
Medullary stromal cells express and present self-antigens that are normally found outside the 
thymus through a process called promiscuous gene expression.  Medullary thymic epithelial cells 
(mTECs) express an enormous range of tissue-restricted antigens, more genes than any other cell 
type (St-Pierre et al., 2013; Sansom et al., 2014).  Promiscuous gene expression is in part driven 
by Fezf2 (Takaba et al., 2015) and Autoimmune Regulator (AIRE), which regulates 3,980 tissue-
restricted genes (Sansom et al., 2014; Mathis and Benoist, 2009).   
Although the mechanism is not entirely understood, strong TCR binding, downstream 
Ca2+ influx, Erk activation, and NFkB inhibition have been shown to be important regulators of 
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negative selection (Daniels et al., 2006; Naeher et al., 2007; Freedman et al., 1999; Mariathasan 
et al., 2001; Yachi et al., 2006; Kane and Hedrick, 1996; Simon et al., 2000; Fiorini et al., 2002).  
Co-stimulation has also been shown to play an important role, as blockade of CD28 binding 
partners B7-1 and B7-2 or CD40 deficiency results in impaired negative selection (Gao et al., 





Figure 1.1  An overview of T cell development in the thymus 
T cell development begins as lymphoid progenitor cells migrate from bone marrow to the 
thymus, where they undergo several stages of development, which are tied to its migration 
through different regions of the thymus.  In order to successfully develop into a T cell that is 
permitted to exit to the periphery, thymocytes must rearrange chains of the T cell receptor, such 
that they may recognize self-MHC but may not interact with self-peptides too strongly.   
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Memory T Cells 
An important property of the adaptive immune system is the ability to form “memory,” or 
to recognize previously encountered pathogens and enact a rapid and robust response, which is 
more efficient than on first exposure.  This process is dependent on the development and 
maintenance of memory lymphocytes.   
After an acute infection, the vast majority of responding cells die by apoptosis 
(McKinstry et al., 2010), which is largely mediated by Bim, Bcl-2, Bcl-x, and Fas dynamics 
(Hildeman et al., 2002; Wojciechowski et al., 2006, 2007; Weant et al., 2008; Hutcheson et al., 
2008).  However, a small population of cells, memory cells, remain and continue to stably persist 
for the lifetime of the organism (Murali-Krishna et al., 1998; Selin et al., 1996).  Memory T cells 
are able to maintain their population independently of antigen persistence and TCR signaling 
(Lau et al., 1994; Mullbacher, 1994; Bruno et al., 1996; Leignadier et al., 2008; Swain, 1999; 
Murali-Krishna, 1999).   Rather, this population is able to survive for very long intervals and 
undergo periodic homeostatic divisions (Zimmerman et al., 1996; Choo et al., 2010).  In CD8 
memory T cells, survival and homeostatic division is dependent on IL-7 and IL-15 signaling 
(Zhang et al., 1998; Schluns et al., 2000; Goldrath et al., 2002; Tan et al., 2002; Becker et al., 
2002; Ku et al., 2000). CD4 memory T cells also depend on IL-7 (Seddon et al., 2003).  Memory 
T cells may be reactivated at much lower concentration of antigen (Pihlgren et al., 1996) and 
express effector molecules IFN-γ and granzyme B more readily than naïve T cells (Fitzpatrick et 
al., 1999; Tanchot et al., 1998).  The differentiation and maintenance of this important subset of 
lymphocytes is the basis for vaccination, whereby the organism’s immune system is induced to 
develop memory cells to more efficiently combat future infection.      
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Models for the generation of a heterogeneous immune response 
One cell, one fate versus one cell, multiple fates 
In the adaptive immune response, generation of both effector and memory cells is 
important for the acute clearance of pathogen and development of immunity to prevent future 
infection.  Generally, there are two different hypotheses for how generation of a heterogeneous 
immune response is accomplished.  The first suggests that one naive cell may only differentiate 
into a single fate, either an effector cell or a memory cell.  The generation of both effector and 
memory cells then depends on diversity within the naïve T cell population or varied priming by 
APCs.  This model is supported by several studies in CD8 T cells, which have shown evidence 
that cell fate is determined at the priming and TCR activation stage (Kaech and Ahmed, 2001; 
van Stipdonk et al., 2003).  Another take on this “one cell, one fate” hypothesis is that temporal 
differences in activation translate into different fates.  For example, some studies have shown 
that timing of stimulation during the course of infection may influence cell fate since important 
determinants may vary at early or late periods of infection (van Faassen et al., 2005; D’Souza 
and Hedrick, 2006; Quigley et al., 2007; Stemberger et al., 2007). 
The second hypothesis suggests that one naïve cell has the potential to give rise to 
multiple cell fates.  This second hypothesis is supported by studies using single cell adoptive 
transfer and barcoding strategies, showing that a single naïve T cell has the potential to generate 
both effector cells and memory cells (Stemberger et al., 2007; Buchholz et al., 2013; Gerlach et 
al., 2010; Plumlee et al., 2013; Tubo et al., 2013; Gerlach et al., 2013).  However, the exact 
pathway of differentiation has been under quite some debate, and there are several models that 




One model of differentiation in response to infection suggests a linear relationship 
between effector and memory cells, where naïve T cells give rise to effector cells upon 
stimulation with cognate antigen, and some of these effector cells differentiate into effector 
memory cells, which then may differentiate into central memory cells (Wherry et al., 2003; 
Harrington et al., 2008; Wu et al., 2002; Hu et al., 2001; Opferman, 1999; Kaech et al., 2002; 
Jacob and Baltimore, 1999; Lauvau, 2001).  However, there is evidence that an effector stage 
may not be required prior to memory cell development (Manjunath et al., 2001).   
 
Decreasing potential model 
An alternative model suggests that effector cells have less potential to differentiate into 
memory cells and greater likelihood of apoptosis as they continue to divide (Renno et al., 1995).  
More divisions correlate to strength and duration of the stimulus.  Therefore, reduced or shorter 
stimulation promotes memory cell development, while strong or prolonged stimulation promotes 
more effector memory and effector cell terminal differentiation (Sarkar et al., 2007; van Faassen 
et al., 2005; Marzo et al., 2005; Wherry et al., 2003; Williams and Bevan, 2004; Jelley-Gibbs et 
al., 2007; Badovinac et al., 2007).  This model seems to also take into account the phenomenon 
of chronic infection, suggesting that stimulation beyond the optimal amount for generation of 
both memory and effector cells may lead to impaired memory or exhausted effector development 




Bifurcative differentiation model and stem cell properties of memory T cells 
Because of their similar properties, memory cells are sometimes compared to stem cells.  
Like stem cells, memory cells are able to maintain their population through self-renewing 
divisions, but are also capable of giving rise to more differentiated effector cells.  Their potency 
is well-illustrated by their ability to reconstitute diverse progeny from a single transferred 
memory cell (Graef et al., 2014).  Because effector cells are considered a terminally 
differentiated population, their generation is dependent on the maintenance of the memory 
population.  The bifurcative differentiation model provides a compelling mechanism for 
generating effector cells without risking loss of the clone to terminal differentiation, inspired by 
a mechanism utilized by stem cells.  This model suggests that one naïve T cell may undergo 
asymmetric cell division, giving rise to two daughter cells with different cell fates.  One daughter 
cell is fated to give rise to effector cells, while the other cell is fated to maintain “stemness” as a 
memory cell.  Using fluorescent microscopy of stimulated and dividing CD4 and CD8 T cells, 
Chang et al. presented evidence of sibling daughter cells with unequal fate determinant protein 
expression and functional profiles as early as the first division (Chang et al., 2007).  Further 
studies have corroborated and built upon these findings, suggesting a role for stimulation 
strength and duration, asymmetric proteasome segregation, and polarity proteins PKCζ and 
PKCλ/ι in the asymmetric cell division of CD8 T cells (Arsenio et al., 2014; King et al., 2012; 
Chang et al., 2011; Metz et al., 2015).  
 
Transcription factors regulating effector and memory T cell differentiation 
There are several transcription factors that have been demonstrated to play important 
roles in the differentiation of effector cells versus memory cells.  Transcription factor T-bet 
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promotes the differentiation of CD8+ effector T cells (Joshi et al., 2007; Intlekofer et al., 2007).  
T-bet has been shown to be positively regulated by inflammatory cytokine IL-12, which couples 
the severity of infection to a stronger effector T cell response (Joshi et al., 2007).  Eomes, 
although it is a homologue of T-bet, promotes CD8+ memory T cell formation rather than 
effector differentiation (Pearce et al., 2003; Intlekofer et al., 2005).  Without Eomes, the memory 
T cell population is poorly maintained (Banerjee et al., 2010; Paley et al., 2013).  Other 
seemingly dichotomous transcription factor pairs exist, where their expression promotes 
opposing cell fates.  For example in CD8+ T cells, Id2 expression is associated with 
differentiation of effector T cells, while Id3 expression is associated with memory cell 
development (Yang et al., 2011; Cannarile et al., 2006; Masson et al., 2013).  Similarly, Blimp-1 
and Bcl6 promote opposing cell fates, where Blimp-1 is associated with effector cell 
differentiation and Bcl6 is associated with memory cell formation and maintenance in both CD8+ 
and CD4+ T cells (Kallies et al., 2009; Rutishauser et al., 2009; Shin et al., 2009; Cui et al., 
2011).  
Additional transcription factors have been associated with the development and 
maintenance of memory T cells.  Tcf1, which is also important during thymocyte development, 
is an important transcription factor for the generation and maintenance of memory T cells (Zhou 
et al., 2010; Jeannet et al., 2010).  FoxO1, forkhead box O1, is also important for memory cell 
formation (Kim et al., 2013; Michelini et al., 2013).  FoxO1 is suggested to bind to the regulatory 
region of TCF1 as well (Kim et al., 2013), further supporting its role in promoting memory T cell 




Transcription factor Foxp3 in regulatory T cells 
Foxp3 has been described as the major transcription factor of regulatory T cell identity in 
mice (Fontenot et al., 2003; Hori et al., 2003; Khattri et al., 2003) and humans (Yagi et al., 
2004).  Spontaneous mutation in the X-linked Foxp3 gene led to the generation of the mouse line 
called ‘scurfy.’  The scurfy phenotype of scaly skin, inflamed eyes, enlarged spleen and lymph 
nodes, and shortened lifespan was the first X-linked disease described in mice (Russell et al., 
1959).  It is now understood that loss of Foxp3 leads to fatal, multi-organ autoimmunity 
(Fontenot et al., 2003; Brunkow et al., 2001; Godfrey et al., 1991) known as 
immunodysregulation polyendocrinopathy enteropathy X-linked syndrome (IPEX) in humans 
(Powell et al., 1982; Bennett et al., 2001; Wildin et al., 2001).   
Expression of Foxp3 is generally limited to T cell subsets with suppressor ability 
(Fontenot et al., 2005c; Wan and Flavell, 2005), although it has been reported that non-
suppressive human CD4+ T cells may transiently express Foxp3 upon activation (Allan et al., 
2007; Miyara et al., 2009).  CD4+ CD25+ Tregs express high amounts of Foxp3, and forced 
expression of Foxp3 in CD4+ CD25- T cells is sufficient to induce a Treg phenotype (Fontenot et 
al., 2003; Hori et al., 2003; Khattri et al., 2003). 
 
Thymic Treg selection 
Another mechanism of central tolerance is the development of regulatory T cells in the 
thymus (tTregs).  There are several models for how tTregs develop in the thymus.  While most 
support the hypothesis that TCR self reactivity is the main determinant, the stochastic-selective 




Van Santen et al. argue that Treg development is shaped by differences in resistance to 
clonal deletion (van Santen et al., 2004).  Using a transgenic mouse with inducible agonist 
peptide expression, they showed that increased peptide expression led to an increase in the 
proportion of Treg cells.  However, the increased frequency was not due to increased 
differentiation as the number of Treg cells was essentially the same.  Rather, the number of 
conventional CD4 T cells undergoing negative selection was increased.  Other groups have also 
argued against the role of TCR specificity in Treg development, including studies suggesting that 
Treg fate determination may occur at the DN thymocyte stage before complete TCR 
rearrangement (Pennington et al., 2006).  These findings are supportive of the selective model, 
which suggests that a TCR-independent signal induces Treg differentiation, and these Tregs have 




There have been many studies that argue for the importance of TCR specificity in the 
development of Tregs.  In TCR transgenic mice, Tregs only develop when their cognate antigen 
is also expressed in the thymus (Jordan et al., 2001; Apostolou et al., 2002; Knoechel et al., 
2005).  Transgenic mice whose TCRs have lower affinity to cognate self-antigen have deficient 
Treg development (Jordan et al., 2001).  These findings support the instructive model (Figure 
1.2), which suggests that Treg development is dependent on TCR avidity to self antigens (Hsieh 
et al., 2012).  Thymocytes that have lower TCR avidity to self-antigen are directed towards a 





Figure 1.2  Instructive model of thymic regulatory T cell development 
The instructive model proposes that regulatory T cell fate is driven by self-reactivity.  
Thymocytes that cannot interact with MHC-presented self-antigen will die by neglect, or fail 
positive selection.  Cells that bind too avidly to MHC-presented self-antigen will die through the 
process of negative selection, which protects against potential autoimmunity.  Those cells that 
have moderate interaction with MHC-presented self-antigen are able to pass positive selection 
and escape negative selection as conventional T cells.  Meanwhile, those cells which have high 
avidity to self-antigen but not strong enough to induce negative selection are fated to become 
regulatory T cells.   
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deleted by negative selection.  tTregs are thought to derive from thymocytes that fall in the 
window of TCR avidity between that of positively selected conventional CD4 T cells and 
negatively selected T cells.   
 
Buddy hypothesis 
Engineering mice with a fixed TCR chain limits TCR diversity, making it more feasible 
to survey and compare TCR repertoires.  Several groups have taken advantage of this strategy, 
revealing that conventional CD4 T cells and Tregs express mostly exclusive TCRs (Fazilleau et 
al., 2007; Hsieh et al., 2006; Pacholczyk et al., 2007; Wong et al., 2007; Wolf et al., 2016; Hsieh 
et al., 2004; Pacholczyk et al., 2006).  These studies are usually invoked in support of the 
instructive model.  However, TCR specificity may not be an absolute fate determinant as the 
estimated overlap between conventional CD4 T cells and Tregs has been reported from 10-40%, 
depending on the study (Fazilleau et al., 2007; Hsieh et al., 2006; Pacholczyk et al., 2007; Wong 
et al., 2007; Wolf et al., 2016; Hsieh et al., 2004; Pacholczyk et al., 2006). 
Chyi-Song Hsieh has proposed the “buddy hypothesis” as an explanation for this TCR 
overlap (Hsieh et al., 2012), which suggests that the shared TCR repertoire may be an 
advantageous mechanism for controlling dangerously autoreactive conventional CD4 T cells 
which may escape negative selection.  If possibly autoreactive conventional CD4 T cells have a 
“buddy” Treg of the same TCR specificity, they may be kept in check, preventing autoimmunity.  






While it has become more convincing that TCR specificity plays an important role in 
Treg differentiation, it may not be the only determinant.  tTreg differentiation seems to lag 
behind conventional CD4 T cell differentiation (Asano, 1996; Fontenot et al., 2005a).  A Foxp3-
CD25+CD4+ SP Treg precursor pool has been identified, which does not depend on TCR 
stimulation to continue differentiation into Foxp3+CD4+ Tregs (Asano, 1996; Fontenot et al., 
2005a; Lio and Hsieh, 2008).  Rather, these Treg precursors require cytokine signaling by IL-2 
or IL-15 to induce Foxp3 expression and assume Treg identity (Lio and Hsieh, 2008).  These 
findings form the basis for the two-step model (Lio and Hsieh, 2008; Hsieh et al., 2012), which 
proposes that the first step towards tTreg development involves strong TCR signaling to self-
antigen with co-stimulation.  This leads to the selection of Treg precursors, which require a 
second step of cytokine signaling with IL-2 or IL-15 to facilitate Foxp3 induction and 
development into tTregs. 
 
Peripherally-induced Tregs 
Tregs may also be induced outside the thymus in the periphery (pTregs) from naïve CD4 
T cells.  This phenomenon has been shown in studies where oral delivery of antigen causes 
differentiation of Tregs outside the thymus (Mucida et al., 2005; Curotto de Lafaille et al., 2008; 
Sun et al., 2007).  The generation of pTregs is most notably described in the intestines.  TGFβ, a 
critical factor for Treg differentiation (Chen et al., 2003; Bettelli et al., 2006; Fantini et al., 2004; 
Mucida et al., 2007; Cobbold et al., 2004; Fu et al., 2004; Rao et al., 2005; Wan and Flavell, 
2005), is abundantly produced by intestinal epithelium (Barnard et al., 1993).  Furthermore, the 
dendritic cells and macrophages residing in gut-associated lymphoid tissue have been shown to 
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promote pTreg development by production of retinoic acid (Sun et al., 2007; Coombes et al., 
2007; Denning et al., 2007; Mucida et al., 2007).   
As the gut is famously colonized by many bacteria, interest has developed in how 
commensal bacteria may affect mucosal immunity.  Interestingly, germ-free mice have reduced 
Treg cells in the intestines, and colonization with bacteria such as Bacteroides fragilis and 
Clostridium species enhances Treg frequency (Geuking et al., 2011; Russell et al., 2012; Round 
et al., 2010; Atarashi et al., 2011, 2013; Lathrop et al., 2011).  Specific pTreg-promoting 
metabolites produced by bacteria have been identified, such as polysaccharide A and short-chain 
fatty acids such as butyrate (Round et al., 2010; Arpaia et al., 2013; Smith et al., 2013; Furusawa 
et al., 2013). 
Like tTreg selection in the thymus, TCR stimulation is important for pTreg generation.  
In a study where the TCR repertoire of intestinal Tregs was screened, most of the intestinal Treg 
TCRs were reactive against intestinal contents or bacterial isolates (Lathrop et al., 2011).  
Furthermore, naïve T cells with these gut microbe-reactive TCRs were able to convert to Tregs 
in the intestines. 
 
In vitro-induced Tregs 
In vitro culture systems have been developed, which allow for the induction of Foxp3 in 
naïve conventional CD4 T cells (Chen et al., 2003).  Although these systems involve TCR 
stimulation in the presence of TGFβ (Shevach and Thornton, 2014), similar to pTregs, one 
should take caution in equating these populations.  Rather, these in vitro-induced Tregs are 
referred to as iTregs (Abbas et al., 2013). 
		25	
In addition to TGFβ and TCR stimulation, iTreg differentiation requires IL-2 (Davidson 
et al., 2007).  CD28 has also been implicated in the process of iTreg differentiation, although its 
role seems to be related on its promotion of IL-2 production. 
iTregs have been shown to be effective in suppressing effector cell function and rescuing 
scurfy mice from autoimmune disease (DiPaolo et al., 2007; Selvaraj and Geiger, 2008; Weber et 
al., 2006; Huter et al., 2008).  However, they may have less effective suppressive function in 
comparison to tTregs in vivo, as some report that iTregs are required at 10 times the 
concentration of nTregs needed to prevent disease (Huter et al., 2008).  This may be due to 
homing deficiencies, as a significant percentage of iTregs seem to lose CD62L expression, and 
therefore may not be able to migrate to lymph nodes properly (Huter et al., 2008; Shevach and 
Thornton, 2014).  It may also be possible that the lower efficiency of iTregs compared to tTregs 
is due to lineage instability (Selvaraj and Geiger, 2008; Yang et al., 2008; Vu et al., 2007; Xu et 
al., 2007; Polansky et al., 2008). 
 
Treg stability and epigenome 
When Tregs are transferred into a healthy host, Foxp3 remains largely stable (Floess et 
al., 2007; Gavin et al., 2007; Komatsu et al., 2009).  However, several studies have shown that in 
lymphopenic or inflammatory conditions, Tregs may lose Foxp3 expression (Gavin et al., 2007; 
Tang et al., 2008; Korn et al., 2007).  These cells which downregulate Foxp3 either die or 
assume effector CD4 T cell phenotype, producing IL-2 and IFNγ, downregulating CD25, GITR, 
and CTLA-4, and failing to suppress effector cells in vitro (Komatsu et al., 2009).  These “ex-
Tregs” may be responsible for causing inflammation and disease, especially since the TCR 
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repertoire is predominantly self-antigen specific (Zhou et al., 2009; Liston and Piccirillo, 2013; 
Mellor and Munn, 2011). 
Epigenomic studies have been a useful tool in the study of Treg stability, as DNA 
methylation has been shown to be a stable and heritable mechanism for gene regulation, where 
unmethylated genes are more easily expressed (Lim and Maher, 2010).  Floess et al. have 
discovered an evolutionarily conserved pattern of CpG demethylation within the Foxp3 locus 
that is present in mature Tregs and not conventional CD4 T cells (Floess et al., 2007).  The 
region of the Foxp3 locus which is involved is referred to as the Treg-specific demethylated 
region (TSDR) (Floess et al., 2007).   
This epigenetic signature was not present in iTregs, with most TSDRs in a methylated 
state, which corresponds to the instability of Foxp3 in iTregs (Floess et al., 2007). 
The importance of epigenetic alterations in the regulation of Foxp3 provides a promising venue 
for therapy to stabilize Treg populations.  In experiments preventing DNA methylation, iTreg 
Foxp3 maintenance was improved four-fold (Polansky et al., 2008).  Ten-eleven translocation 
enzyme (TET) has also been shown to regulate stability of Foxp3 by maintaining demethylated 
status of important regions of the Foxp3 gene, such as CNS1 and CNS2, and TET activators like 
vitamin C may be used to promote iTreg stability (Yue et al., 2016). 
While IL-2 has been shown to be important for iTreg induction, it also plays an important 
role in maintaining Foxp3 expression.  Addition of IL-2 improves Foxp3 stability in iTregs both 
in vitro and after in vivo transfer (Chen et al., 2011; Webster et al., 2009).  Activated effector 
cells have been shown to be an important source of the IL-2, which promotes Foxp3 maintenance 
in iTregs in vivo (Chen et al., 2011).  IL-2 helps to maintain the population of iTregs through 
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both promoting proliferation of Foxp3+ Tregs and promoting demethylation of TSDRs via 
STAT5 signaling, stabilizing Foxp3 expression (Chen et al., 2011).   
Unlike iTregs, nTregs do not depend on IL-2 for development.  However IL-2 is 
important for maintenance of in vivo Tregs (Fontenot et al., 2005b; D’Cruz and Klein, 2005), and 
addition of IL-2 neutralizing antibody results in impaired Treg maintenance (Murakami et al., 
2002; Setoguchi et al., 2005), similar to iTregs. 
 
Metabolism and the immune system  
Although immunology and metabolism have formerly been separate fields of study, their 
intersection has become a growing field unto itself.  Because the immune system involves many 
different cell types with a wide range of metabolic needs to accomplish their many functions, it 
follows that these metabolic pathways have become more widely appreciated for their role in 
development and identity of immune cells.  
 
Naïve T cells and oxidative phosphorylation 
Naïve T cells are normally resting, with low energy requirements.  Therefore, they 
possess a catabolic metabolism, where oxidative phosphorylation (OXPHOS) is primarily 
used to generate ATP (Buck et al., 2015).  OXPHOS is highly efficient in the production of 
ATP.  In this process, FADH2 and NADH, products of the tricarboxylic acid cycle, act as 
electron donors in the electron transport chain found in the inner membrane of mitochondria.  
Electrons are shuttled between various inner membrane-associated complexes (Figure 1.3) 
(Dimeloe et al., 2017).  Complexes I, III, and IV can use the energy derived from the transfer 







Figure 1.3  Electron transport chain in oxidative phosphorylation 
NADH or FADH2 may donate electrons to the electron transport chain, which shuttles the 
electron through multiple complexes embedded in the mitochondrial inner membrane.  
Transfer of the electron facilitates the formation of a hydrogen gradient across the inner 
membrane, which drives ATP synthase/Complex V production of ATP.   




The accumulation of H+ in the intermembrane space establishes an electrochemical potential, 
which can then be used by Complex V to synthesize ATP from ADP.    
 
Memory cells and fatty acid oxidation 
Like naïve cells, memory cells are generally inert and have low energy requirements.  
However, they preferentially use fatty acid oxidation (FAO), which feeds into OXPHOS to 
generate ATP (van der Windt et al., 2012, 2013).  The triacylglycerides which are 
metabolized via FAO are synthesized from citrate from glycolysis, rather than being taken up 
from the environment (O’Sullivan et al., 2014; Cui et al., 2015).  This process is essential for 
memory T cell survival and the ability to respond quickly to rechallenge, with rapid 
proliferation and cytokine production (O’Sullivan et al., 2014; Cui et al., 2015; van der Windt 
et al., 2013).   
 
T cell activation inducing PI3K/AKT/mTOR signaling 
T cell stimulation has been demonstrated to result in activation of phosphoinositide-3-
kinase (PI3K) (Lafont et al., 2000; Cantrell, 2001; Fruman and Cantley, 2002; Ward et al., 1992), 
which occurs within seconds (Ward et al., 1993; Costello et al., 2002; Harriague and Bismuth, 
2002).  PI3K activity has been shown to be sustained for at least the first 9 hours of activation, 
which is crucial for inducing cell proliferation (Costello et al., 2002).   
How PI3K is activated through signaling by the TCR is not entirely understood.  
Transmembrane proteins TCR-interacting molecule (TRIM) and linker for activation of T cells 
(LAT) have also been proposed to couple PI3K to TCR signaling as TRIM has an intracellular 
domain motif which may be phosphorylated after TCR stimulation (Bruyns et al., 1998).  PI3K 
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activation is likely facilitated by costimulatory receptors CD28 and ICOS that associate closely 
with the TCR, as both contain PI3K-binding motifs where the regulatory subunit of PI3K may 
dock (Truitt et al., 1994; Prasad et al., 1994; Coyle et al., 2000).  CD28 has also been shown to 
activate PI3K independently of the TCR (Ward et al., 1993).   
PI3K is a conserved enzyme family which has evolved in multicellular eukaryotes for 
several functions such as vesicular trafficking, cell growth and survival, and cell metabolism 
(Engelman et al., 2006).  PI3Ks may be divided into 3 classes based on their structure: class I, 
class II, and class III.  Of these classes, Class I PI3K has been the best described in its function in 
lymphocytes.  Class I PI3Ks are heterodimers composed of catalytic subunit p110 and a 
regulatory subunit.  Class IA PI3Ks are activated by receptor tyrosine kinases (RTKs), including 
antigen, co-stimulatory, and cytokine receptors, while Class IB PI3Ks are activated by G protein 
coupled receptors (GPCRs), including chemokine receptors (Okkenhaug and Vanhaesebroeck, 
2003).  The preferred substrate of Class I PI3Ks is phosphatidylinositol-(4,5)-bisphosphate 
(PIP2), which it converts into phosphatidylinositol-(3,4,5)-trisphosphate (PIP3) at the plasma 
membrane (Okkenhaug and Vanhaesebroeck, 2003) (Figure 1.4).  PIP3 reportedly accumulates 
in the region near the immunological synapse (Costello et al., 2002; Harriague and Bismuth, 
2002), but may also accumulate at a second site, on the pole opposite of the synapse (Costello et 
al., 2002). 
PIP3 functions as a binding site for enzymes with pleckstrin homology (PH) domains, 
including 3-phosphoinositide dependent protein kinase-1 (PDK1) (Currie et al., 1999; Komander 
et al., 2004) and the serine/threonine kinase Akt, also referred to as Protein Kinase B (Franke, 
1997; Klippel et al., 1997).  PDK1 and Akt co-localization at the membrane facilitates PDK1  
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Figure 1.4  PI3K signaling in T cells 
PI3K signaling is induced from T cell receptor (TCR) activation, although the exact mechanism 
is not entirely understood.  Transmembrane proteins TRIM, LAT, CD28, and ICOS, which are 
closely associated with the TCR, have been proposed to couple TCR signaling to PI3K 
activation.  PI3K signaling initiates a network of signaling cascades including the activation of 
AKT and mTOR, which orchestrate many aspects of T cell biology such as differentiation, 
proliferation, and cell death.  Figure from (Okkenhaug and Vanhaesebroeck, 2003) 
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phosphorylation of Akt on Thr308 (Alessi et al., 1997; Stephens et al., 1998; Stokoe et al., 1997).  
Akt may also be phosphorylated on Ser473 by the mTOR-Rictor complex (mTORC2) (Sarbassov 
et al., 2005; Facchinetti et al., 2008).  mTORC2-activated Akt can phosphorylate FoxO 
transcription factors (Guertin et al., 2006; Brunet et al., 2001), which results in their inhibition 
via exclusion from the nucleus and degradation (Brunet et al., 1999; Kops et al., 1999).   
Although mTOR can regulate Akt, Akt also regulates mTOR.  The mTOR-Raptor 
complex (mTORC1) is positively regulated by the GTPase Rheb (Tee et al., 2003; Parmar and 
Tamanoi, 2010).  Akt phosphorylates and inactivates tuberous sclerosis protein 2 (TSC2) (Cai et 
al., 2006; Inoki et al., 2002), which inhibits Rheb activity by catalyzing the hydrolysis of Rheb-
GTP to Rheb-GDP (Inoki et al., 2003; Tee et al., 2003). Therefore, Akt acts to disinhibit Rheb 
activity, promoting mTORC1 activation.   
Akt has a parallel mechanism of mTOR regulation through proline-rich Akt substrate 
40kDa (PRAS40), a binding partner of mTORC1.  PRAS40 binds and inhibits mTORC1 activity 
(Vander Haar et al., 2007; Sancak et al., 2007; Wang et al., 2007).  However, Akt 
phosphorylation of PRAS40 destabilizes the interaction between PRAS40 and mTORC1, 
allowing mTORC1 activity to be restored (Wang et al., 2007; Sancak et al., 2007). 
Akt signaling promotes glucose transporter upregulation and surface presentation (Kohn 
et al., 1996; Cong et al., 1997; Ueki et al., 1998; Barthel et al., 1999; Taha et al., 1999; Wang et 
al., 1999).  In resting T cells, Glut1 expression is very low (Rathmell et al., 2000).  However 
upon activation, T cells upregulate Glut1 on the cell surface in a PI3K/Akt pathway-dependent 
manner (Frauwirth et al., 2002; Wieman et al., 2007; Jacobs et al., 2008).  Activated T cells also 
increase their glycolytic metabolism (Rathmell et al., 2003).  Inhibition of the PI3K/Akt pathway 




The process of glycolysis begins with the cell taking in glucose from the environment, 
which may be facilitated by glucose transporters.  Through several metabolic steps, glucose is 
converted into pyruvate (Figure 1.5).  In the presence of oxygen, pyruvate may be oxidized into 
acetyl-CoA and shuttled through the citric acid cycle (TCA cycle) and OXPHOS, where one 
glucose molecule may yield 30-32 ATPs.  In situations where there is insufficient oxygen, 
pyruvate may undergo fermentation, whereby lactate dehydrogenase converts pyruvate into 
lactate.  This process results in only a net gain of 2 ATP molecules generated per glucose 
molecule.  
 
Effector T cells and aerobic glycolysis 
As activated cells must undergo proliferation and perform effector functions to control 
infection, one would expect their metabolic demands to be increased.  To meet these high 
bioenergetics demands, it might be assumed that they would utilize OXPHOS, which produces 
more ATP per molecule of glucose than glycolysis alone.  However, it has been demonstrated 
that even with sufficient oxygen, effector T cells preferentially utilize the glycolytic pathway, 
allocating as much as 70% of glucose towards production of lactate and only 30% towards 
OXPHOS (Roos and Loos, 1973).  This phenomenon of aerobic glycolysis has also been 
demonstrated in tumor cells and is commonly referred to as the Warburg Effect.  Aerobic 
glycolysis may not be just a consequence of malignant transformation however, as it has been 
shown to be a requirement for tumor growth (Shim et al., 1998; Fantin et al., 2006).  Cancer 
biologists and immunologists have suggested that aerobic glycolysis actually synthesizes ATP at 
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a faster rate than OXPHOS (Liberti and Locasale, 2016).  Furthermore, besides ATP production, 
aerobic glycolysis generates metabolites and reducing equivalents which may feed into many 




Figure 1.5  Aerobic glycolysis 
In the cytoplasm, the enzyme hexokinase utilizes ATP to convert glucose into glucose-6-
phosphate, which effectively traps it within the cell.  Glucose-6-phosphate may be isomerized by 
phosphoglucose isomerase into fructose-6-phosphate.  Phosphofructokinase utilizes ATP to 
phosphorylate fructose-6-phosphate to become fructose-1,6-bisphosphate, which may be split by 
fructose bisphosphate aldolase into isomers dihydroxyacetone phosphate (DHAP) and 
glyceraldehyde-3-phosphate.  Isomerization between DHAP and glyceraldehyde-3-phosphate is 
catalyzed by triose phosphate isomerase.  Conversion from DHAP into glyceraldehyde-3-
phosphate is promoted by the consumption of glyceraldehyde-3-phosphate as glyceraldehyde-3-
phosphate dehydrogenase converts glyceraldehyde-3-phosphate into 1-3-bisphophoglycerate, 
reducing NAD+ into NADH in the process.  As phosphoglycerate kinase converts 1-3-
bisphosphoglycerate into 3-phosphoglycerate, it also phosphorylates a molecule of ADP, 
producing ATP.  3-phosphoglycerate isomerizes into 2-phosphoglycerate before enolase converts 
it into phosphoenolpyruvate (PEP).  As pyruvate kinase catalyzes PEP into pyruvate, another 




















Asymmetric Metabolic Signaling Driving Developmental  










Proper development of metazoan organisms involves careful spatial and temporal cellular 
patterning.  As embryos begin as a single cell and develop to have various tissues with distinct 
functionalities, it follows that there must be mechanisms to orchestrate the divergence of cell 
fates.  We demonstrate that unequal transduction of nutrient-sensitive PI3K/AKT/mTOR 
signaling during cell division bifurcates the transcriptional network and fate of kindred T cells.  
In the process of PI3K-dependent CD8 effector T cell determination, one differentiating daughter 
cell downregulates transcription factor TCF1, while its sibling cell with weaker PI3K signaling 
self-renews in parallel.  In divisions preceding this fate determination stage, asymmetric 
metabolic signaling specifies a more proliferative, differentiation-prone T cell in tandem with a 
quiescent memory cell sibling.  Therefore, we propose a model whereby metabolic signaling is 
not only characteristic of cell identity, but also instructive of the transcriptional circuitry of 







Development and maintenance of the various tissues of metazoan organisms requires 
complex arrangements in cell fate determination.  This process requires that some cells divide 
and give rise to daughter cells that adopt divergent fates.  Divergence of identities may occur 
after a mitotic event, whereby identical daughter cells receive unequal developmental cues by 
virtue of their positions within a signaling gradient (Restrepo et al., 2014).  Alternatively, fate 
divergence may occur during cell division from polarization of cell fate determinants, referred to 
as asymmetric cell division (Neumüller and Knoblich, 2009).   
Stem cells famously utilize asymmetric cell division to generate differentiated tissue 
while self-renewing its stem cell population.  The mechanism for how various stem cells 
accomplish this seemingly paradoxical task is still not entirely understood, and investigation into 
this question is of immense interest, particularly in relevance to regenerative medicine and 
cancer biology (Blanpain and Fuchs, 2014).  Similar to the stem cell response to tissue injury, 
immune cells respond to infection by giving rise to terminally differentiated effector cells while 
also regenerating less differentiated memory cells.  Therefore, asymmetric cell division has also 
been investigated for its role in generating cell fate diversity in the immune response.  Evidence 
from our lab has demonstrated asymmetric cell division being utilized by CD4 T cells, CD8 T 
cells, and B cells (Chang et al., 2007; Ciocca et al., 2012; Barnett et al., 2012; Nish et al., 2017; 
Lin et al., 2016).   
Both stem cells and immune cells must adapt their cellular metabolism to support the 
proliferative burst initiated by damage or infection.  Upon activation, immune cells give rise to 
terminally differentiated effector cells, which adopt a metabolic program of glycolytic anabolism, 
which has been compared to the Warburg metabolism of cancer cells, where the process of 
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glycolysis is favored over oxidative phosphorylation (OXPHOS) despite sufficient exposure to 
oxygen (Vander Heiden et al., 2009; Liberti and Locasale, 2016; Buck et al., 2015).  Meanwhile, 
the self-renewal of a less differentiated memory lymphocyte requires mitochondrial oxidative 
catabolism (Buck et al., 2015).   
While it is increasingly appreciated that cells with diverse functionality require different 
metabolisms, how the bifurcation of metabolic programs interacts with the bifurcation of cell fate 
has not been fully investigated.  Previous studies have suggested that lymphocyte cell fate 
decisions may be linked to cell division (Hodgkin et al., 1996; Bird et al., 1998).  Here we 
explore the divergence of transcription factor circuitry in the process of differentiation versus 
self renewal in sibling cells, and examine its relation to the evolutionarily conserved, nutrient-
sensitive PI3K/AKT/mTOR pathway.  This pathway has been shown to couple proliferation to 
metabolic reprogramming, and in doing so, may subsequently instruct cell proliferation, fate, and 
function (Vander Heiden et al., 2009; Ward and Thompson, 2012; Shyh-Chang et al., 2013; 
Pollizzi and Powell, 2014; Man and Kallies, 2015; Buck et al., 2015).  Our studies suggest that 
irreversible differentiation of one daughter cell is tethered to self-renewal by its sibling cell, 
which is seemingly driven by unequal anabolic activation through nutrient-sensitive PI3K 





Effector T cell determination during self-renewing divisions 
TCF1, which is encoded by the Tcf7 locus, is an essential transcription factor of T cell 
development in the thymus (Germar et al., 2011; Weber et al., 2011).  It has been implicated in 
promoting the self-renewal of memory cells as well as in repressing the differentiation of effector 
cells (Gattinoni et al., 2009; Zhou et al., 2010; Zhao et al., 2010; Jeannet et al., 2010; Zhou and 
Xue, 2012; Tiemessen et al., 2014).  After a naïve CD8+ T cell is activated during infection, it 
gives rise to a terminally differentiated effector T cell, which facilitates immunity against the 
pathogen by secreting cytotoxic perforin and granzymes and inducing apoptosis of infected cells.  
This effector cell differentiation is accompanied by the downregulation of TCF1 via epigenetic 
silencing (Scharer et al., 2013).  Using flow cytometry, we examined the pattern of TCF1 
expression in relation to CD8+ T cell division, which was stereotyped across responses to 
different pathogens and recapitulated during rechallenge of memory cells (Figure 2.1A, 2.3B).  
TCF1 expression is maintained through the first few divisions, but after approximately 3 or 4 
divisions, some cells repress TCF1 while some maintain expression.  Consistent with prior 
studies (Boudousquié et al., 2014; Jeannet et al., 2010; Tiemessen et al., 2014; Zhou and Xue, 
2012; Zhou et al., 2010), the loss of TCF1 expression gave rise to the terminally differentiating 
KLRG1-expressing effector T cell population (Figure 2.1A). 
By microscopy, we examined sibling cell pairs activated by infectious challenge as well 
as from an in vitro model of T cell differentiation.   We found that loss versus maintenance of 
TCF1 expression could be seen in clonally related descendants (Figure 2.1B).  IRF4, a 
transcription factor which is expressed in proportion to T cell receptor signaling strength, has 
been shown to play a crucial role in the expansion and differentiation of effector T cells (Man et 
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al., 2013; Nayar et al., 2014; Yao et al., 2013; Raczkowski et al., 2013).  Furthermore, it is 
promoted by PI3K/AKT/mTOR signaling in T cells (Yao et al., 2013).  IRF4 is expressed at 
intermediate levels during the early divisions and increases at approximately the stage where T 
cells begin repression of TCF1 (Figure 2.1C).  Microscopy of singlet cells demonstrated that 
high expression of IRF4 was correlated with low TCF1 expression (Figure 2.1D).  Furthermore, 
microscopy revealed that conjoined sibling cells frequently demonstrated reciprocal expression 
of TCF1 and IRF4 (Figure 2.1E).  These finding suggest that in CD8+ T cells, self-renewal is 
coupled to differentiation during an asymmetric cell division.    
 
Asymmetric nutrient-sensitive signaling driving bifurcation of T cell fates 
IRF4-induced effector T cell differentiation has been demonstrated to be positively 
regulated by mTOR signaling (Yao et al., 2013).  Sustained AKT activation has also been shown 
to promote effector T cell differentiation (Kim et al., 2012).  When the PI3K/AKT/mTOR 
pathway is inhibited, memory cell development is promoted instead (Araki et al., 2009; Pearce et 
al., 2009).  We found that inhibition of PI3K or mTOR signaling in activated CD8+ T cells 
prevented the repression of TCF1 and limited the expression of differentiation markers such as 
Blimp and KLRG1, which was also recapitulated in the rechallenge of memory CD8+ T cells 
(Figure 2.2A).   
TCF1 expression in memory T cells is dependent on FoxO1 activity (Kim et al., 2013; 
Michelini et al., 2013), which is inactivated by PI3K signaling (Manning and Cantley, 2007).  
Using FoxO1 inactivation (exclusion from the nucleus) as an indicator of PI3K activity, we were 
able to examine conjoined sibling cells for evidence of unequal metabolic signaling.  The sibling 
cell with higher IRF4 (and therefore repressed TCF1, Figure 2.1E) possessed FoxO1 that was 
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excluded from the nucleus, while the sibling cell with lower IRF4 intensity maintained FoxO1 
that was localized to the nucleus (Figure 2.2B).  We found that c-Myc, the major anabolism-
associated transcription factor of activated T cells (Wang et al., 2011), also seems to be induced 
in a PI3K/mTOR-dependent manner (Figure 2.2C).  Similar to our findings with IRF4, c-Myc 
expression was unequal and reciprocally expressed in relation to TCF1 at the onset of TCF1 
repression (Figure 2.2D).  When treated with mTOR inhibitor rapamycin, we found decreased 
expression of c-Myc and more equal expression of TCF1 between conjoined sibling cells (Figure 
2.2E).  Together, these findings suggest that CD8 effector T cell determination is coupled to 
memory cell renewal since effector differentiation appears to be tethered to a cell division with 
unequal metabolic signaling.  
 
Nutrient-sensitive branching in fate specification prior to determination 
Despite the stability of TCF1 expression in early cell divisions (Figure 2.1A, 2.1C), it is possible 
that PI3K signaling may still be unequal between sibling cells.  By microscopy, we demonstrate 
that PI3K-sensitive transcription factors IRF4 and c-Myc (Lin et al., 2015) (Figure 2.2C) were 
expressed unequally between sibling cells prior to the inactivation of FoxO1 and loss of TCF1 in 
either cell (Figure 2.3).  Conjoined CD8+ T cell sibling pairs within the first 3 divisions generally 
had bilateral expression of TCF1 and FoxO1 nuclear localization but unequal nutrient-sensitive 
signaling, as indexed by asymmetric IRF4 and c-Myc (Figure 2.3A).  T cells that only divided 
one or two times in vivo and remained lower for IRF4 preferentially populated the bone marrow, 
which is the preferred site for homeostatic self-renewal (Figure 2.3B).  Meanwhile, cells with 
higher IRF4 expression demonstrated greater proliferation and progressed towards TCF1 
repression and heightened IRF4 induction.  These cells also seemed to localize at sites of 
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infection like the spleen.  These findings are compatible with a model where asymmetric 
nutrient-sensitive signaling in early divisions of the immune response specifies the generation of 
a more proliferative, effector-prone sibling as well as a more quiescent memory cell sibling 





Our study illustrates the growing appreciation for the role of metabolic regulation in 
influencing the fate and function of normal and cancerous cells (Buck et al., 2015; Man and 
Kallies, 2015; Pollizzi and Powell, 2014; Shyh-Chang et al., 2013; Vander Heiden et al., 2009; 
Ward and Thompson, 2012).  For many years, it has been known that various cell types have 
characteristic metabolisms that aid in the execution of their particular functions.  However, more 
attention has been drawn to the idea that these heterogeneous metabolic states may not simply be 
a consequence of their cellular identities.  Metabolic states and the nutrient-sensing signals that 
direct them may actually drive cell fate decisions by regulating various factors that impact 
lineage choices.   
The mechanism upstream of the demonstrated asymmetry in PI3K signaling intensity has 
yet to be fully elucidated.  Asymmetry of inheritance of antigen, costimulatory, or cytokine 
receptors could be possible candidates upstream of unequal PI3K signaling (Chang et al., 2007; 
Ciocca et al., 2012; Barnett et al., 2012; Arsenio et al., 2014).  Unequal distribution of AKT 
molecules, which has been described in dividing cancer cells (Dey-Guha et al., 2011), is another 
possible candidate.   
Mitochondria can modify signaling and metabolism, depending on the organelles’ level 
of fitness (Chandel, 2015).  Clearance of aged mitochondria has been shown to promote the self-
renewal of muscle, hematopoietic, and breast stem cells (García-Prat et al., 2016; Ito et al., 2016; 
Katajisto et al., 2015).  Mitochondrial quality has also been demonstrated to influence natural 
killer cell memory formation and B cell fate determination (O’Sullivan et al., 2015; Jang et al., 
2015).  Unequal inheritance of aged mitochondria has been proposed as a mechanism to regulate 
self-renewal in stem cells (Katajisto et al., 2015).  Work in our lab has also discovered that 
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activated B and CD8+ T cells may give rise to daughter cells with unequal clearance of aged 
mitochondria, and this mitochondrial stasis, which is linked to a constellation of anabolic 
metabolism, marks T cells which are destined for differentiation, while the other daughter cell is 
destined for a self-renewed cell fate (Adams et al., 2016).   
An ancestral polarity network including Par proteins and atypical protein kinase C 
(aPKC) has been implicated in controlling asymmetric cell divisions in several different cell 
types (Neumüller and Knoblich, 2009).  In lymphocytes, it has also been shown that cell-to-cell 
contacts may initiate polarity cues and asymmetric partitioning of cell fate determinants, leading 
to cell fate bifurcation (Barnett et al., 2012; Chang et al., 2007).  However, the asymmetric 
divisions we have demonstrated in this study may not be completely dependent on external 
polarity cues, since findings are recapitulated with diffusible stimuli in buoyant media.  
Furthermore, metaphase stage divisions lacked obvious asymmetry of cell fate determinants, 
although evident during cytokinesis.  This has led us to believe the mechanism for establishing 
asymmetry occurs after telophase, when may allow for private signaling of sibling cells (Habib 
et al., 2013). 
In order to develop heterogeneous cell tissues from a single-celled embryo, metazoans 
must utilize mechanisms of pattern formation to ensure proper spatial and temporal 
differentiation.  We have suggested that lymphocyte cell fate diversification utilizes asymmetric 
cell division, where a mitotic event leads to bifurcation of cell fate in daughter cells.  From our 
study, we propose that unequal metabolic signaling in dividing CD8 T cells may drive cell fate 
bifurcation, allowing for the diversification of cell types needed to execute effective immune 
responses.  Although the upstream regulators of this phenomenon have yet to be identified, our 
findings may still open the opportunity for the utilization of metabolism-altering strategies for 
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manipulating lymphocyte development in the treatment of cancer, chronic infection, or 
development of vaccines. 
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MATERIALS AND METHODS 
Mice 
All animal work was done in accordance with Institutional Animal Care and Use 
Guidelines of Columbia University.  Mice were housed in specific pathogen-free conditions prior 
to infectious challenges.  C57BL/6 (wild type and CD45.1 or Thy1.1 congenic mice), P14 TCR 
transgenic mice recognizing LCMV peptide gp33-41/Db, Blimp-1-YFP (Fooksman et al., 2010), 
and GFP-c-Myc knock-in (Huang et al., 2008) mice have been previously described. 
 
Adoptive transfers 
CD8+ T cells were purified with CD8a+ T Cell Isolation Kit (Miltenyi Biotec) from 
lymph nodes and spleens of P14 mice.  1-3 x 106 CD8+ T cells were labeled with CFSE dye or 
Cell Trace Violet dye (Invitrogen) and adoptively transferred i.v. into C57BL/6 or B6.SJL mice.  
 
Immunization and infectious challenges 
Primary infectious challenges consisted of either 2 x 105 PFU of lymphocytic 
choriomenigitis virus Armstrong strain (LCMV) by i.p. injection or 5 x 103 Listeria 
monocytogenes expressing gp33-41 (LMgp33) by i.v. injection.  For CD8+ T cell re-challenge 
experiments, 2.5 x 107 proliferation dye-labeled splenocytes were transferred from LCMV-
infected P14 recipients at day >120 p.i. to naïve mice. One day after transfer, secondary 
recipients were infected i.v. with 5 x 103 LMgp33. 
 
Cell culture 
To activate naïve CD8+ T cell in vitro, plain or P14+ CD8+ T cells were purified with the 
		48	
CD8+ T Cell Isolation Kit (Miltenyi Biotec), labeled with cell proliferation dye, and activated 
with immobilized anti-CD3 (5 µg/ml), soluble anti-CD28 (1 µg/ml), and recombinant IL-2 (30 
IU) or in the presence of gp33 peptide (1 µg/ml; Anaspec) and congenic naïve splenocytes.  Anti-
CD3 was diluted in PBS for coating of flat-bottomed plates.  For in vitro memory CD8 T cell 
reactivation, spleens were harvested at 120+ days after LCMV infection from mice that had 
received Thy1.1+ P14 CD8+ T cells.  Total splenocytes were labeled with a proliferation dye and 
cultured in the presence of gp33 peptide (1 µg/ml) for 4.5 days. Memory P14 CD8+ T cells were 
analyzed after gating on Thy1.1+ cells.  Small molecule inhibitors of PI3K (LY294002; Cell 




After immunization and systemic infection, cells were harvested from the spleen and 
bone marrow and prepared using standard techniques.  Single-cell suspension was prepared by 
filtering cells with a 70 µm cell strainer and lysed by ACK Buffer.  Surface staining was carried 
out on ice for 30-60 min in PBS+ containing 2% fetal bovine serum and 2 mM EDTA. Cells 
were fixed and permeabilized with eBio Fix/Perm kit to stain for transcription factors. Dead cells 
were eliminated using red, green, or violet amine reactive dyes (Invitrogen).  
Antibodies against CD45.1 (A20), CD45.2 (104), KLRG1 (2F1), and IRF4 (3E4) were from 
eBioscience; CD44 (IM7), CD45.2 (104), and Thy1.1 (OX-7) were from Biolegend; CD4 (RM-
45) and CD25 (PC61) were from BD; TCF1 (C63D9) was from Cell Signaling; CD4 (RM-45) 
and CD8 (5H10) were from Invitrogen. BD LSRII/Fortessa and FACSAria II flow cytometers 
with FACSDiva software were used to analyze and/or purify cells. Data was analyzed using 
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Flowjo v.8.8.7 (Treestar). 
 
Confocal microscopy 
Sorted cells were immediately transferred to poly-L-lysine coated #1.5 coverglass and 
allowed to adhere prior to 3% paraformaldehyde fixation.  Cells were rehydrated in PBS+ 
containing 50 mM NH4Cl, permeabilized with 0.3 % Triton X-100 in PBS+ (blocking solution) 
and then treated with 0.01 % saponin and 0.25 % fish skin gelatin (Sigma) in PBS+. Staining 
with primary antibodies and secondary antibodies was carried out sequentially for 1h at room 
temperature. Antibodies (derived from the following species) against the following antigens were 
used: (rat) α-tubulin (Abcam; YOL1/34), (mouse) β-tubulin (Sigma; AA2), (rabbit) anti-TCF1 
(Cell Signaling; C63D9), (rat) anti-IRF4 (eBio; 3E4), (rabbit) anti-c-Myc (Abcam; Y69), (rabbit) 
anti-FoxO1 (Cell Signaling; C29H4), (mouse) anti-GFP CF488 (Sigma-Aldrich; 9F9.F9), and 
(rabbit) anti-GFP AF488 (Cat.# A-21311; Invitrogen).  Primary antibodies were detected using 
goat anti-mouse, anti-rat and anti-rabbit antibody conjugated directly to AF488, Al568, AF647 
(Invitrogen).  DNA was stained and coverglasses were mounted with ProlongGold with DAPI 
(Invitrogen).  Images were acquired on a Zeiss LSM710 laser scanning inverted confocal 
microscope controlled by Zeiss Zen software (2010 SP1, v.6) and equipped with a Zeiss 
63x/1.40 NA oil immersion objective and 405nm diode, 488nm argon, 561nm DPSS, and 633nm 
HeNe lasers.  Where indicated, a Nikon Ti Eclipse inverted confocal laser scanning microscope 
equipped with a 60x/1.40 NA oil immersion objective was used.  Pinhole size, pixel dwell time, 
frame size, resolution, and slice thickness were optimized using Zen software.  Each cell 
required 15-30 sections to cover z-dimension.  Transmitted light from the 405nm laser was 
captured on a transmission-PMT unit. ImageJ (v.1.46r) or Fiji (v.2.0) software was used to 
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project the total z-stack, apply a minimal smooth filter for some displayed images, rotate, change 
pseudocolors, convert to RGB, and add scale bars. Total fluorescence in defined regions of 
single cells was quantitated using the integrated density function in ImageJ. 
Cells undergoing cytokinesis were identified from their cytoplasmic cleft by transmitted 
light and defined tubulin bridge staining, plus the additional presence of dual nuclei using DAPI 
DNA stain.  Mitotic blasts were selected based on the specific appearance of tubulin staining and 
condensed DAPI staining.  Nonparametric one-way ANOVA was used to determine significance. 
P<0.05 was significant.  A cell was determined to be asymmetric if the ratio of a molecule’s 
fluorescence on either side of the plane of division was greater than that of the mean of tubulin 






Figure 2.1  Effector T cell determination during self-renewing divisions 
(A) Naïve P14 CD8+ T cells were transferred to congenic mice and infected with either Listeria 
monocytogenes expressing gp33-41 (LMgp33) or lymphocytic choriomeningitis virus (LCMV).  
Upper rows:  TCF1 expression versus cell division in transferred CD8+ T cells at indicated times 
after infection.  Lowest plot:  KLRG1 versus TCF1.  Data are representative of three separate 
experiments.  (B) Left:  representative images of unequal TCF1 expression between sibling 
CD8+ T cells after infection with LCMV or in vitro activation.  Right:  Summary of TCF1 
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microscopy data from donor P14 T cells 3-4 days post-infection or in vitro activation of naïve 
P14 T cells with gp33 peptide/splenocytes for 3 days.  Cells were stained for TCF1, tubulin, and 
DNA.  Asymmetric TCF1 expression was found in conjoined siblings after LMgp33 infection 
(62%; n=34 sibling pairs), LCMV infection (75%; n=33 sibling pairs), and in vitro stimulation 
(55%; n=29 sibling pairs).  Scale bars, 5µm.  Graphs display the ratio of total TCF1 fluorescence 
in each sibling pair.  Pie charts summarize the overall incidence of TCF1 asymmetry.  (C) FACS 
analysis of donor P14 T cells after 3 days of LMgp33 infection.  Data are representative of four 
experiments.  (D) IRF4 intensity by confocal microscopy (mean ± SD) of singlet cells with 
indicated TCF1 status among donor P14 T cells 3-4 days after LMgp33 infection.  TCF1 hi 
n=11; TCF1 lo n=17.  (E) Representative images of reciprocal IRF4 and TCF1 expression in 
sibling donor P14 T cells 3-4 days after infection.  Graph displays ratio of IRF4 fluorescence in 
each sibling pair.  Left pie chart summarizes overall incidence of IRF4 asymmetry (52%; n=25 
sibling pairs).  Right pie chart summarizes frequency of sibling pairs with reciprocal IRF4 and 
TCF1 (61%), concordant IRF4 and TCF1 (15%), and symmetric TCF1 (23%) among pairs with 






Figure 2.2  Asymmetric PI3K signaling bifurcating T cell fates 
(A) Nutrient-sensitive signaling driving TCF1 repression.  Naïve CD8+ T cells were stimulated 
with plate bound anti-CD3 and soluble anti-CD28 for 6.5 days.  Memory P14 T cells were re-
stimulated with gp33 peptide for 4.5 days, with or without inhibitors of PI3K (5 µM) and mTOR 
(0.5 µM).  (B) Microscopy of IRF4 and FoxO1 expression in conjoined sibling donor T cells 3-4 
days after LMgp33 infection or naïve P14 T cells 3 days after in vitro stimulation.  Two 
representative sibling pairs with asymmetric IRF4 and concordant cytoplasmic FoxO1 are 
displayed (from LMgp33 infection, n=33 sibling pairs; from in vitro activation, n=19 sibling 
pairs).  Pie charts summarize frequency of IRF4 and FoxO1 cytoplasmic/nuclear asymmetry.  
IRF4 asymmetry in conjoined sibling cells: 63% after LMgp33 infection and 68% after in vitro 
activation.  Of cells with asymmetric IRF4 expression, (top) 62% of LMgp33-infected and 
(bottom) 77% of in vitro activated conjoined sibling cells had asymmetric FoxO1, where higher 
IRF4 corresponded with cytoplasmic FoxO1.  28% of LMgp33-infected and 15% of in vitro 
activated sibling pairs had nuclear FoxO1 in both cells.  No pairs with asymmetric IRF4 had 
cytoplasmic FoxO1 in both cells.  (C) c-Myc expression sensitive to PI3K and mTOR.  GFP-c-
Myc P14 T cells were stimulated in vitro with gp33 peptide with or without inhibitors of PI3K (5 
µM) and mTOR (0.5 µM) for 48 hours.  (D) Representative conjoined sibling pairs after naïve 
GFP-c-Myc P14 T cells were stimulated with gp33 in vitro for 3 days and sorted from the fourth 
division onward.  Left pie chart summarizes overall incidence of c-Myc asymmetry (58%; n=26 
sibling pairs).  Right pie chart summarizes frequency of conjoined sibling pairs with reciprocal c-
Myc and TCF1 (67%), concordant c-Myc and TCF1 (20%), and symmetric TCF1 (13%) among 
sibling pairs with asymmetric c-Myc.  (E) P14 GFP-c-Myc T cells activated in vitro with or 
without inhibitor of mTOR (0.5 µM) for 3 days and sorted from the fourth division onward.  
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Graph displays ratio of TCF1 fluorescence in sibling pairs with (n=17 sibling pairs) or without 
(n=26 sibling pairs) of mTOR inhibitor rapamycin.  Pie charts summarize incidence of TCF1 







Figure 2.3  PI3K-driven branching in early T cell fate specification 
(A) Representative images of asymmetric IRF4 and c-Myc in sibling T cells prior to divisions 
yielding TCF1 repression or FoxO1 inactivation.  Naïve P14 or polyclonal CD8+ T cells 
activated in vitro after 30-40 hours, when cells have undergone only 1-3 divisions.  Graphs 
display ratio of TCF1, IRF4, and c-Myc fluorescence in sibling pairs.  25% of pairs had 
		57	
asymmetric TCF1 (n=25).  47% of pairs had asymmetric IRF4 (n=43).  44% of pairs had 
asymmetric c-Myc (n=24).  Of sibling pairs where both cells maintain TCF1 expression, 57% 
had asymmetric IRF4 (n=16) and 60% had asymmetric c-Myc (n=15).  Of sibling pairs with 
asymmetric IRF4 as well as asymmetric c-Myc, 83% had concordant asymmetry.  50% of sibling 
pairs had nuclear/nuclear FoxO1 in both cells, 31% had nuclear/cytoplasmic (asymmetric) 
FoxO1, and 19% had cytoplasmic/cytoplasmic FoxO1 (n=16 sibling pairs).  IRF4 expression 
was asymmetric in 50% of pairs with nuclear/nuclear FoxO1, 80% of pairs with asymmetric 
FoxO1, and 33% of pairs with cytoplasmic/cytoplasmic FoxO1.  (B) Localization of P14 T cells 



















Regulatory T cells (Tregs) are crucial for suppressing autoimmunity and inflammation 
mediated by conventional T cells. To be useful, the specificity of some Tregs should overlap 
with the specificity of relevant self-reactive or pathogen-specific clones. Whether matching 
specificity between Treg and non-Treg cells arises through stochastic or deterministic 
mechanisms has not been addressed. We tested the hypothesis that some of the Tregs that arise in 
the thymus or are induced during antigen-driven expansion of conventional CD4+ T cells are 
clonally related to non-Treg cells by virtue of an asymmetric cell division during Foxp3 
induction. We isolated CD4+ thymocytes dividing in vivo wherein sibling cell pairs contained 
discordant expression of Foxp3. Under conditions that stimulate induced Tregs from 
conventional CD4+ T cells in vitro we found a requirement for cell cycle progression to achieve 
Foxp3 induction. Moreover, a substantial fraction of sibling cell pairs arising from induced Treg 
stimulation contained discordant expression of Foxp3. Division-linked yet asymmetric induction 
of Tregs offers a plausible mechanism for the robust formation of a regulatory T cell repertoire to 
anticipate peripheral self-reactivity as well as the de novo production of precision counter-
regulation during CD4+ T cell-mediated immune responses.   
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BACKGROUND 
Regulatory T cells (Tregs) are a CD4+ T cell subset that expresses the X-linked 
transcription factor Foxp3 and plays an essential role in avoidance of autoimmunity and 
collateral tissue damage during immune responses. Deficiency of Foxp3, the major lineage-
defining transcription factor of Tregs in mice (Fontenot et al., 2003; Hori et al., 2003; Khattri et 
al., 2003) and humans (Yagi et al., 2004) leads to fatal, multi-organ autoimmunity (Fontenot et 
al., 2003; Brunkow et al., 2001; Godfrey et al., 1991) known as immunodysregulation 
polyendocrinopathy enteropathy X-linked syndrome (IPEX) in humans (Powell et al., 1982; 
Bennett et al., 2001; Wildin et al., 2001).  
During the development of thymic regulatory T cells (tTregs), Foxp3 is induced in 
response to TCR signaling (Sekiya et al., 2013). Studies in TCR transgenic mice with expression 
of the cognate antigen have elucidated the important role of TCR specificity to self antigen in the 
differentiation of tTregs (Jordan et al., 2001; Apostolou et al., 2002; Knoechel et al., 2005; 
Kawahata et al., 2002; Walker et al., 2003). Furthermore, tTreg selection is promoted by a high 
degree of TCR affinity to self antigen (Moran et al., 2011; Carter et al., 2005; Jordan et al., 2001; 
Cozzo Picca et al., 2011). These findings are consistent with an instructive model of tTreg 
development, where TCR affinities guide thymocyte cell fate (Hsieh et al., 2012). This model 
suggests that the range of TCR affinities to self antigen which promote Treg development is 
higher than that which instructs positive selection of conventional T cells, but limited by that 
which induces negative selection.  
While TCR signaling is an important determinant in Treg development, other factors 
such as co-stimulation through CD28 (Lohr et al., 2004; Tai et al., 2005) and cytokine signaling 
have also been shown to play crucial roles (Vang et al., 2008; Lio and Hsieh, 2008). A two-step 
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model suggests that in addition to a TCR-dependent phase of Treg selection which poises a 
Foxp3-CD25+ Treg precursor cell to express Foxp3, there is also a subsequent TCR-independent 
phase, where cytokine signaling, especially by IL-2, is crucial for the induction of Foxp3 
expression (Lio and Hsieh, 2008).  
It has been suggested that there is some TCR overlap between Tregs and conventional 
CD4 T cells (Fazilleau et al., 2007; Hsieh et al., 2006; Pacholczyk et al., 2007; Wong et al., 
2007; Wolf et al., 2016; Hsieh et al., 2004; Pacholczyk et al., 2006). Although selected single-
positive thymocyte populations contain few proliferating cells, the characteristics of minority 
subpopulations have not been fully interrogated (Penit and Vasseur, 1993; Bautista et al., 2009). 
We utilized confocal microscopy to visualize rare, dividing thymocytes that express Foxp3 and 
discovered a substantial frequency of discordance in expression of Foxp3 between kindred cells. 
Our results provide a potential explanation for how some convergence in the antigen receptor 





Thymic Tregs may arise during an asymmetric cell division 
We utilized GFP-Foxp3 fusion protein reporter mice, Foxp3gfp (Fontenot et al., 2005c) 
and confocal microscopy to study the characteristics of dividing Tregs in the thymus. CD4+CD8- 
(CD4SP) GFP+ cells were sorted from thymus prior to fixation and fluorescent staining. In order 
to enrich for cells undergoing later stages of cell division in vivo, events with forward light 
scatter properties (area versus height) indicative of cell doublets were included (Figure 3.1A).  
While doublets are rare events, typically <5% of cells (data not shown), even fewer are 
actually dividing cells. During microscopy, we used a combination of criteria that has been 
shown to specifically discriminate between adjacent-but-unrelated cells from actual sibling cell 
pairs in telophase or cytokinesis (Lin et al., 2015). Bona fide sibling cell pairs contained a bridge 
structure evident by transmitted light and fluorescent tubulin staining, as well as distinct nuclei 
within each lobe of the doublet. Among the doublets that met the criteria for being authentic 
sibling cells, we then assessed the signal of GFP-Foxp3 with a combination of anti-GFP staining 
and GFP emission within same fluorescence channel. Of the cytokinetic pairs with at least one 
GFP+ daughter cell, we found 63% had discordant expression of GFP-Foxp3 between daughters 
(Figure 3.1B, 3.1C).    
To ensure the phenomenon was not specific to Foxp3gfp mice, we also examined 
thymocytes from wild-type (WT) mice. We sorted on CD4SP CD25+ cells (Figure 3.2A) in order 
to enrich for Tregs and Treg precursors (Lio and Hsieh, 2008).  We found 74% of cytokinetic 
doublets with at least one Foxp3+ cell had asymmetric expression of Foxp3 (Figure 3.2B, 3.2C), 
similar to findings in reporter mice.  In further support of the notion that the Tregs examined in 
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these studies are thymically derived, Helios was expressed on >90% of singlet and doublet 
Foxp3+ thymocytes (Figure 3.3). 
 
Foxp3 induction may be cell cycle-dependent and transmitted unequally 
Tregs may also arise in the periphery from naïve CD4 T cells (pTregs) or in vitro from 
conventional CD4 T cells stimulated in the presence of TGFβ (iTregs). In an effort to explore 
other modes of Treg generation, we extended our query to an in vitro iTreg model.  Naïve 
Foxp3gfp CD4+ T cells labeled with cell proliferation dye, which initially do not express Foxp3 
(Figure 3.4A), were able to divide and give rise to Foxp3+ iTregs in response to stimulation with 
plate-bound antibodies against CD3 and CD28, IL-2, and increasing concentrations of TGFβ 
(Figure 3.4B).  A population of Foxp3+ cells appears as early as 1 day post-stimulation, which is 
maintained and increases over several days and divisions (Figure 3.4B).   
Under induction conditions that allowed for the development of both Foxp3+ and Foxp3- 
progeny (0.1ng/mL TGFβ), we found Foxp3 induction to be substantially inhibited by drugs that 
arrest the cell cycle at the G1 (mimosine) or G2/M (nocodazole) phases (Figure 3.5A, 3.5B). In 
contrast, Cytochalasin B, which arrests cells after mitosis and during cytokinesis, had little effect 
on Foxp3 induction. It is unlikely that the defect in Foxp3 induction was simply due to a 
nonspecific defect in activation or ability to maintain gene expression, as evidenced by the 
expression of CD44 and CD62L (Figure 3.5A). 
To determine whether our findings of asymmetric Foxp3 in dividing thymocytes also 
extended to iTreg differentiation, we examined the Foxp3 expression pattern of nascent sibling 
cells under iTreg stimulatory conditions.  Of conjoined sibling pairs with at least one GFP+ cell, 
33% exhibited asymmetric induction of GFP-Foxp3 (Figure 3.6A, 3.6B), confirming that the cell 
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cycle-dependent induction of Foxp3 can be transmitted unequally in the late stage of cell division. 
Cells in metaphase exhibited symmetrical distribution of Foxp3 protein in thymocytes as well as 
in vitro (Figure 3.7), suggesting that unequal signaling in late mitosis, rather than unequal 
inheritance of the pre-formed Foxp3 protein is responsible for differential gene expression in 






Many models of Treg development suggest that Treg selection is determined by the 
strength and specificity of the TCR to self antigen (Hsieh et al., 2012). Thymocytes with low 
TCR affinities to selecting ligands undergo positive selection and develop into conventional CD4 
T cells. Those with very high TCR affinities to self-antigen undergo negative selection as a 
mechanism to eradicate possibly autoreactive lymphocytes. Regulatory T cells may prevent 
autoimmunity by possessing overlapping specificity to self-antigen but remain under the 
threshold for negative selection.  
The finding of unequal expression of Foxp3 in dividing thymocytes as well as CD4 T 
cells in Treg-inducing conditions, suggest that Tregs may arise as a result of asymmetric cell 
division. We speculate that strong TCR interactions accompanied by appropriate cytokine 
signaling (Lohr et al., 2004; Tai et al., 2005; Fontenot et al., 2005b; Vang et al., 2008; Lio and 
Hsieh, 2008), which are apparently required for Treg selection, may trigger cell division at low 
frequency (Penit and Vasseur, 1993; Bautista et al., 2009). If induction of Tregs is cell cycle-
dependent, then it is possible that a previously described mechanism that silences Foxp3 during 
cell division (Li et al., 2014; Feng et al., 2014) may be antagonizing stable induction in one of 
two daughter cells. This model would serve to explain why some overlap exists between TCR 
repertoires of Tregs and conventional CD4 T cells (Hsieh et al., 2004, 2006, Pacholczyk et al., 
2006, 2007; Wong et al., 2007; Fazilleau et al., 2007; Wolf et al., 2016) by enabling clones to 
yield a conventional CD4+ T cell alongside a Treg sibling cell with identical TCR.  
We cannot currently exclude the possibility that the conventional CD4+ sibling cell from 
the asymmetric thymocyte divisions is destined for apoptosis by negative selection (Daley et al., 
2013), rather than surviving as a viable CD4+ thymocyte. It also remains to be determined 
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whether peripheral Tregs that arise from conventional CD4+ T cells during in vivo immune 
responses are the product of an asymmetric cell division in situ. Lymphocyte effector and 
memory fate diversification has been suggested to occur as a result of asymmetric nutritive 
signaling (Nish et al., 2017; Lin et al., 2015, 2016; Adams et al., 2016; Pollizzi et al., 2016). 
Cellular metabolism also plays an important role in Treg differentiation and stability (Delgoffe et 
al., 2009; Wei et al., 2016). Future studies will be needed to determine whether unequal 
metabolic signaling plays a role in discordant expression of Foxp3 in dividing thymocytes and 
induced Tregs. Nonetheless, the ability to couple Foxp3 induction to an asymmetric division 




MATERIALS AND METHODS 
Mice and in vitro Treg induction 
Mice were housed under specific pathogen-free conditions and used in accordance with 
protocols approved by Columbia University’s Institutional Animal Care and Use Committee and 
guidelines outlined by National Institutes of Health. Thymi were isolated from 4- to 6-week-old 
wild-type (WT) C57BL/6 and Foxp3gfp (Fontenot et al., 2005c) mice. Spleen and lymph nodes 
for in vitro induction cultures were isolated from 6- to 14-week-old WT and Foxp3gfp mice. 
Naïve CD4+ T cells were purified from spleens and lymph nodes by magnetic cell separation 
(Miltenyi Biotec) or cell sorting for CD4+CD8-TCRβhiCD25-CD44loCD62Lhi cells on a 
FACSAria II cell sorter (BD Biosciences) prior to labeling with cell proliferation dye CellTrace 
Violet (Thermo Fisher). Cells were cultured for 36 hours at 5 x 105 cells per well in 48-well 
tissue culture plates pre-coated with anti-CD3 (1 µg/mL, BD Bioscience) and anti-CD28 (1 
µg/mL, BD Bioscience) antibodies plus 100 U/mL recombinant human IL-2 (National Cancer 
Institute Biological Resources Branch), and 0.1 ng/mL recombinant human TGFβ (R&D 
Systems) in RPMI1640 (Gibco) supplemented with 10% fetal bovine serum (Gemini), 100U/ml 
penicillin (Gibco), 100U/ml streptomycin (Gibco), non-essential amino acids (Gibco), 1mM 
sodium pyruvate (Gibco), 2mM GlutaMAX (Gibco), 10mM HEPES (Gibco), and 55uM 2-
mercaptoethanol (Gibco). Cell cycle inhibitors were added at the start of cell culture: 2.5 mM L-
Mimosine (Sigma) and 5 or 10 µg/mL Nocodazole (Cell Signaling Technologies). 10 µM 
Cytochalasin B (Sigma) was added for the final 16 hours of culture.  
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Flow cytometry 
Live/Dead Fixable Red or Live/Dead Fixable Aqua (Invitrogen) staining was performed 
at 4 °C or on ice for 15 min in PBS. Surface antibody staining was performed at 4 °C or on ice 
for 20 min in PBS containing 2% fetal bovine serum and 2mM EDTA. For staining intracellular 
transcription factors, fixation and permeabilization was performed with the eBioscience 
Intracellular Fixation & Permeabilization Buffer Set Kit, prior to intracellular staining for 1 hour 
at 4 °C or on ice. Antibodies for flow cytometry included CD4 (RM4-5, Invitrogen), CD8 (53-
6.7, eBioscience), CD25 (PC61, BD Biosciences), CD44 (IM7, eBioscience), CD62L (MEL-14, 
BD Biosciences), and Foxp3 (FJK-16S, eBioscience). Cells were analyzed or sorted on LSRII, 
LSRFortessa, and FACSAria II flow cytometers (BD Biosciences) with BD FACSDiva software. 
Data analysis was performed using FlowJo v.10.2 (Tree Star).  FACS data presented in Figure 3 
are gated on forward scatter/side scatter properties indicative of singlet lymphocytes, and live 
CD4+ CD8- cells. 
 
Confocal microscopy 
Cells were seeded onto poly-L-Lysine (Sigma) coated coverslips (Fisher Scientific) and 
allowed to adhere briefly before fixation with 4% paraformaldehyde (Sigma), quenching with 50 
mM NH4Cl (Sigma), permeabilization with 0.3% Triton X (Sigma), and blocking with 0.25% 
fish skin gelatin (Sigma) and 0.01% saponin (Sigma) in PBS. Antibodies include: rat anti-β-
tubulin (YOL1/34, Abcam), rabbit anti-Foxp3 (C29H4, Cell Signaling Technologies), mouse 
anti-GFP CF 488 (9F9.F9, Sigma), goat anti-rat Alexa Fluor 488 (Life Technologies), goat anti-
rat Alexa Fluor 568 (Life Technologies), goat anti-rabbit Alexa Fluor 568 (Life Technologies). 
ProLong Gold Antifade Mountant with DAPI (Invitrogen) was used to mount coverslips and 
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stain DNA. Cells were stained with primary antibodies for 1hr at room temperature or 4°C 
overnight, followed by washing in blocking buffer. Secondary antibodies were stained for 1hr at 
room temperature. Washes were done with blocking buffer. Images were acquired on a Zeiss 
LSM710 or Nikon Ti Eclipse inverted confocal microscopes and processed using Fiji v2.0.0-rc-
43/1.51q software (Schindelin et al., 2012). Transmitted light and tubulin images shown are of a 
single z-plane. DAPI and Foxp3 images shown are sum slices projections. Asymmetry of DAPI 
and Foxp3 was calculated from projections as (integrated density daughter 1 – integrated density 
daughter 2) / (integrated density daughter 1 + integrated density daughter 2), with values over 0.2 
considered asymmetric.  
 
Statistics 
Statistical analyses were performed using Prism (GraphPad). Significance between Foxp3 
and DAPI asymmetry values was determined using two-tailed t tests for paired data. Significance 
for drug-treatment effect on Foxp3 induction was determined using repeated-measures one-way 






Figure 3.1  Discordant expression of Foxp3 reporter in sibling CD4SP thymocytes 
(A) Sorting strategy applied to thymocytes from Foxp3gfp mice: CD4+CD8-GFP+ cells, inclusive 
of doublets to prevent loss of cytokinetic pairs. The GFP+ gate was drawn generously to include 
cytokinetic pairs with unequal GFP-Foxp3 expression that may be measured as having 
intermediate intensity. (B) Conjoined sibling cells from sort of Foxp3gfp thymus undergoing 
cytokinesis. Cells were stained with DAPI against DNA, anti-β-tubulin antibody, and anti-GFP 
antibody. Cytokinetic pairs were identified by initial visualization of β-tubulin staining of bridge 
between adjacent cells, followed by verification by transmitted light prior to evaluation of DNA 
and GFP-Foxp3. Signal shown in the “Foxp3” panel is both from GFP-Foxp3 and anti-GFP 
antibody. Top, 6 representative sibling pairs with asymmetric GFP-Foxp3 expression, 2 
representative sibling pairs with symmetric GFP-Foxp3 expression. Scale bars 5um. (C) Top, 
Quantification of GFP-Foxp3 asymmetry in cytokinetic pairs with at least one GFP+ sibling 
(n=35). ***p<0.001 compared to DNA. Dotted line denotes asymmetry value of 0.2, where 
values greater than 0.2 are considered asymmetric. Bottom, Pie chart summarizing frequency of 




Figure 3.2  Discordant expression of Foxp3 in sibling CD4SP thymocytes  
(A) Representative sorting strategy applied to thymocytes from WT mice: CD4+CD8-CD25+ 
cells, inclusive of doublets. (B) Conjoined sibling cells from sort of WT thymus undergoing 
cytokinesis. Cells were stained with DAPI for DNA, anti-β-tubulin antibody, and anti-Foxp3 
antibody. Top, 6 representative sibling pairs with asymmetric Foxp3 expression, 2 representative 
sibling pairs with symmetric Foxp3 expression. Scale bars 5um. (C) Top, Quantification of 
Foxp3 asymmetry in cytokinetic pairs with at least one Foxp3+ sibling (n=19). ***p<0.001 
compared to DNA. Dotted line denotes asymmetry value of 0.2, where values greater than 0.2 
are considered asymmetric. Bottom, Pie chart summarizing frequency of cytokinetic pairs with 





Figure 3.3  Helios expression among CD4SP Foxp3+ thymocytes 
Representative flow cytometry analysis of live-staining singlet and doublet thymocytes.  Of 





Foxp3 expression versus cell proliferation dye in iTreg induction cultures.  WT naïve CD4 T 
cells were enriched from spleen and lymph nodes and stained with cell proliferation dye.  (A) 
Prior to stimulation, most cells did not express transcription factor Foxp3.  (B) These cells were 
then stimulated in vitro in anti-CD3 and anti-CD28 coated wells in the presence of IL-2 and 
0.05ng/mL, 0.1ng/mL, or 1ng/mL TGFβ.  Cells were analyzed for Foxp3 expression over the 
course of 4 days of stimulation.   
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Figure 3.5  Foxp3 induction dependent on cell cycle progression in vitro 
(A) Naïve CD4 T cells were isolated from Foxp3gfp mice, labeled with cell proliferation dye, and 
stimulated in vitro for 36 hours in Treg-inducing conditions prior to FACS analysis. Indicated 
groups of cells were also treated initially with either Mimosine (2.5 mM) or Nocodazole (5 or 10 
ug/mL); or for the final 16 hours with Cytochalasin B (10 uM). Representative FACS plots of 
indicated protein versus cell proliferation dye in live CD4+ lymphocytes.  Foxp3 signal is the 
sum of GFP-Foxp3 emission plus anti-Foxp3 antibody staining. (B) Quantification of frequency 
of live CD4SP cells expressing Foxp3 at day 1.5 of in vitro Treg induction (n=4). ***p<0.001 
compared to untreated.    
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Figure 3.6  Discordant expression of Foxp3 in induced Tregs 
(A) Naïve CD4 T cells were isolated from Foxp3gfp mice and stimulated in vitro for 1.5 days in 
Treg-inducing conditions prior to microscopy. Cells were stained with DAPI for DNA, anti-β-
tubulin antibody, and anti-GFP antibody. Conjoined sibling cells from in vitro Treg-induction 
culture undergoing cytokinesis. Signal shown in the “Foxp3” panel is both from GFP-Foxp3 
emission and anti-GFP antibody. Six representative sibling pairs with asymmetric GFP-Foxp3 
expression and 2 representative sibling pairs with symmetric GFP-Foxp3 expression are shown. 
Scale bars 5um. (B) Left, Quantification of GFP-Foxp3 asymmetry in cytokinetic pairs with at 
least one GFP+ sibling (n=27). **p<0.01 compared to DNA. Dotted line denotes asymmetry 
value of 0.2, where values greater than or equal to 0.2 are considered asymmetric. Right, Pie 





Figure 3.7  Symmetric expression of Foxp3 in metaphase cells 
(A) Representative images of CD4SP cells from thymus of WT and Foxp3gfp mice during 
metaphase, as indicated by two microtubule spindles on opposite ends of the cell, with DNA 
concentrated in the center between them.  Foxp3-expressing metaphase cells generally displayed 
symmetric distribution of the transcription factor.  (B) Representative images of WT and 
Foxp3gfp cells from iTreg in vitro induction cultures after approximately 1.5 days of stimulation.  




















Metazoans start as single-celled embryos, which must accomplish the task of 
proliferating and developing diverse organs made up of different tissues and cell types.  
Successful development depends on careful spatial and temporal orchestration of cell fate 
bifurcations.  However, the creation of cell fate heterogeneity is not limited to the process of 
embryogenesis.  Adult stem cells are charged with the responsibility of regenerating damaged 
tissues throughout the lifetime of the organism.  To accomplish this feat, stem cells possess two 
remarkable characteristics: the ability to give rise to more differentiated cell types and the ability 
to self-renew its stem cell population.  The ability to give rise to more differentiated cells is an 
obvious necessity in order to regenerate somatic tissues.  However, the ability to self-renew 
underlies the remarkable power of sustained tissue regeneration over many years.  One could 
imagine a scenario in which all stem cells of the body are simply able to differentiate, without 
self-renewal.  Especially as stem cells are a rare population, they could quickly become 
completely differentiated.  At which point, there would be no stem cells left to respond to 
damage.  
Stem cells are famously able to accomplish these two feats of differentiation and self-
renewal through a single mitotic event, referred to as asymmetric cell division.  Asymmetric cell 
division has been demonstrated in many stem cell types.  However, light has been shed on the 
possibility of asymmetric cell division being utilized by non-stem cell populations. 
The requirement for the development of cell heterogeneity extends beyond the process of 
embryogenesis and tissue regeneration by stem cells.  In the adaptive immune response to 
infection, lymphocytes become activated and must give rise to differentiated effector type cells 
with very different functionality as compared to their naïve counterparts.  Memory cells, whose 
etiology has been a point of controversy in the immunology community, are more similar to 
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naïve cells in their ability to become activated and give rise to effector cells upon subsequent 
infection.  Like stem cells, lymphocytes’ ability to give rise to differentiated progeny as well as a 
more self-renewed population underlies their proper functioning.  
Work in our lab and others has elucidated that lymphocytes are also able to utilize 
asymmetric cell division to generate cell fate heterogeneity.  Our lab has developed a method in 
which lymphocyte cytokinetic sibling pairs may be visualized by fluorescent microscopy and 
evaluated for evidence of asymmetric cell division.  Using these techniques, our lab has 
demonstrated polarity of cell fate determinants, which may be driven by ancestral polarity 
networks and unequal proteasome segregation (Chang et al., 2007, 2011).  In this dissertation, I 
have presented my contribution to this saga of exploring asymmetric cell division in lymphocyte 
fate diversification, in CD8+ T cells as well as in regulatory T cells. 
 
Chapter 2 
We present evidence of cell fate diversification in activated CD8+ T cells by 
demonstrating the downregulation of TCF1 in a portion of cells that have divided at least 3-4 
times.  These findings may be replicated with in vitro and in vivo activation of naïve CD8+ T 
cells as well as in rechallenge of CD8+ memory T cells.  By confocal microscopy, we show that 
repression and maintenance of TCF1 expression could be seen in opposite daughter cells of the 
same mitotic event, where the TCF1-repressed, IRF4hi cell has adopted effector cell fate, and the 
TCF1-maintained, IRFlow cell has a more self-renewed memory cell fate.  
Due to growing appreciation of metabolism for its role in enabling immune function and 
the fact that IRF4 has been implicated downstream of nutrient-sensitive PI3K/mTOR/AKT 
pathway, we wanted to investigate how signaling in this pathway may influence our findings of 
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asymmetric cell division in CD8+ T cells.  In divisions with asymmetric expression of TCF1 
between daughter cells, we have witnessed asymmetric metabolic signaling.  TCF1 repression of 
one daughter cell corresponds to having stronger anabolic signaling, based on IRF4, inactivated 
FoxO1, and c-Myc.  Furthermore, inhibition of the nutrient-sensitive PI3K/mTOR pathway led 
to loss of the development of a TCF1 repressed effector cell population and decreased 
asymmetric cell division.  Together, these findings suggest that unequal metabolic signaling 
between daughter cells drives cell fate bifurcations of activated CD8+ T cells. 
The data presented in chapter 2 was included as part of a larger manuscript, which 
showed similar findings in B cells giving rise to plasma cells (Lin et al., 2015).  A couple years 
later, another lab member published her findings, suggesting that asymmetry of anabolic 
signaling also regulated the asymmetric cell division of CD4+ T cells into Th1 effector T cells 
(Nish et al., 2017).  Together, these findings suggest that metabolism-driven asymmetric cell 
division may be a conserved mechanism used by many cell types for establishing heterogeneity 
of daughter cells.   
 
Chapter 3 
We have also demonstrated evidence for the possibility of asymmetric cell division 
giving rise to regulatory T cells. Among CD4SP thymocytes, we demonstrate unequal expression 
of Foxp3, the major transcription factor regulating Treg development.  We are also able to find 
asymmetric Foxp3 expression between cytokinetic sibling cells in a model of in vitro-induced 
Tregs.  Although we cannot rule out the possibility that asymmetric Foxp3 expression is a result 
of one daughter cell receiving a post-mitotic differentiation cue, we have shown evidence in 
iTregs that the induction of Foxp3 may be dependent on the ability to undergo cell division.   
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 We are currently doing experiments to help clarify some details that have been presented 
in chapter 3.  For example, one unanswered question is in divisions giving rise to daughter cells 
of unequal Foxp3 expression, what is the fate of the sibling that does not express Foxp3?  With 
our current data, we have not established whether or not this Foxp3- cell is destined to survive 
and exist in the periphery.  As Treg selection is thought to be driven by strong TCR avidity to 
self-antigen, this cell may have a self-reactive TCR, and its survival and exit to the periphery 
may induce autoimmunity.  To establish the likelihood of the Foxp3- sibling cell exiting into the 
periphery versus undergoing apoptosis in the thymus, we plan to evaluate Helios expression by 
confocal microscopy.  Helios has been described as a marker of strongly autoreactive CD4 T 
cells destined to undergo negative selection and apoptosis (Daley et al., 2013).  By visualizing 
Helios expression in the Foxp3- sibling cell, we may gain some insight into the likelihood of its 
survival versus cell death.   
  As metabolic signaling seems to play an important role in the differentiation and self-
renewal of CD8+ T cells in response to infection, it would be interesting to determine if a similar 
mechanism is utilized in the differentiation of Tregs.  We have generated some data visualizing 
pS6, which is downstream of mTOR activity, in these Foxp3-asymmetric divisions.  However, a 
discernable pattern has yet to be established with the current data.  We are also planning to 
interrogate the PI3K signaling pathway in these cells by imaging PIP3, a product downstream of 
PI3K activation.  Since work by other members of our lab has suggested that PIP3 may be 
polarized as early as the metaphase stage of division, we may find more success in visualizing 
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